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ZUSAMMENFASSUNG 
Die Alzheimer-Krankheit (AD) ist durch synaptische Fehlfunktionen, eine Dysregulation des 
neuronalen Netzwerkes und darauf folgende Gedächtnisstörungen gekennzeichnet. Der 
Hippocampus ist für Lern- und Gedächtnisfunktionen unverzichtbar und sehr früh von der 
charakteristischen Pathologie der Krankheit betroffen. Wie genau die Bildung oder auch das 
Abrufen von Gedächtnisinhalten gestört wird, wurde noch nicht hinreichend geklärt. Die 
vorliegende Studie untersuchte die Beteiligung individueller Nervenzellen an der Bildung und 
dem Abrufen von Erinnerungen und eruiert mögliche Fehlfunktionen in einem präklinischen 
AD Model. Die Zwei-Photonen Intravitalmikroskopie wurde benutzt um repetitiv die 
Aktivität individueller Nervenzellen während einer hippocampus-abhängigen Lern- und 
Gedächtnisaufgabe zu verfolgen. Die untersuchte CA1-Region des Hippocampus wies hierbei 
zwei unterschiedliche Nervenzellpopulationen auf. Diese unterschieden sich hinsichtlich ihrer 
stabilen beziehungsweise wechselhaften Einbindung in das aktive Netzwerk. Nervenzellen 
letzterer Population wurden während des Lernens und Erinnerns in das aktive Netzwerk 
rekrutiert und somit als Träger der Erinnerung identifiziert, als sogenanntes Engramm. In 
einem Mausmodell, das Aspekte der Alzheimer-Krankheit repräsentiert (APP/PS1 Mäuse), 
wies die generelle Aktivität der CA1 Pyramidenzellen sowie das für den Erinnerungsprozess 
wichtige Engramm keine Abweichungen auf. Jedoch wurden im Erinnerungsnetzwerk der 
APP/PS1 Tiere zusätzlich aktivierte Nervenzellen identifiziert, die zu einer Überlagerung der 
Erinnerung und einer damit verbundenen Gedächtnisstörung führten. Durch künstliches 
Erzeugen dieser überlagernden Aktivität in experimentell gesunden Mäusen konnte ihre 
Gedächtnisfähigkeit vermindert und die Hypothese der Erinnerungsüberlagerung bestätigt 
werden. Des Weiteren wurde die Bedeutung von hippocampalen PV-positiven (PV+) 
Interneuronen bei Lern- und Gedächtnisprozessen bewiesen. Eine mögliche Unterfunktion 
ihrer hemmenden Leistung auf CA1 Pyramidenzellen könnte der vorher beschriebenen 
Überlagerung zugrunde liegen. Abschließend wurde ein durch Lernen induzierter Verlust von 
dendritischen Dornenfortsätzen im Stratum Radiatum der CA1 Pyramidenzellen gesunder 
Mäuse untersucht. Diese strukturelle Veränderung stellt einen potentiellen 
Selektionsmechanismus dar, der nicht in APP/PS1 Tieren nachgewiesen wurde. 
Zusammenfassend liefert die vorliegende Arbeit wichtige Erkenntnisse bezüglich der 
Charakteristika eines Engramms und deckt einen neuen Mechanismus der hippocampalen 
Gedächtnisstörung bei der Alzheimer-Krankheit auf.  
ABSTRACT 
Alzheimer’s disease (AD) is characterized by synaptic dysfunction and progressive memory 
loss. The hippocampus is indispensable for memory processes and early affected by disease-
associated pathology. It is still debated how in particular encoding and retrieval of memories is 
impaired in AD. Therefore, the current study investigated how individual neurons in the 
hippocampus encode a memory and whether this process is disturbed under AD-like 
conditions in a pre-clinical model. To achieve this goal a cutting-edge technology – two-
photon in vivo imaging – was used to repetitively analyze the activity of neurons in the 
hippocampus throughout a hippocampus-dependent memory test. Initially, this study revealed 
two populations of hippocampal CA1 neurons that differ in their long-term activity: a subset 
of neurons was continuously active over several days, whereas another population showed 
variable activity. The latter provided the population that responded to memory encoding as 
well as retrieval and hence, formed the cellular memory trace, also known as engram. 
Interestingly, network activity and engram formation under AD-like conditions (APP/PS1 
mice) was intact. However, a further analysis of neurons composing the “retrieval network” 
identified an additional neuronal ensemble in CA1 that superimposed the memory trace 
suggesting a causal relationship of memory trace superimposition and memory impairment. 
Indeed, mimicking superimposition by artificial activation of a non-related memory trace 
coding a different context caused reduced memory performance in healthy mice and thus, 
presents a potential mechanism for impaired memory retrieval in APP/PS1 mice. Furthermore, 
parvalbumin-expressing (PV+) interneurons in CA1 were indispensable for successful memory 
encoding and retrieval in healthy mice. Their functional impairment represented a potential 
explanation of the observed engram superimposition in APP/PS1 mice. Finally, a learning-
related loss of synaptic connections was discovered on dendrites of CA1 pyramidal neurons in 
healthy mice suggesting a mechanism of synaptic selection important for encoding of new 
information. Learning-induced changes of synaptic connectivity were absent in APP/PS1 mice 
indicating that synaptic connectivity deficits might be causally related to memory trace 
superimposition and ultimately memory impairment under AD-like conditions. Summarized, 
the present study provides a refinement of the engram’s characteristics and furthermore, 
identifies a novel mechanism of memory impairment on the cellular and synaptic level in a 
mouse model of AD.  
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1. INTRODUCTION 
Our mind, one of the most difficult things to understand, defines our personality and 
constitutes who we are. It sets us apart from other creatures, gives us independence, shape and 
an identity. Hence, suffering from loss of memories that represent a substantial part of our 
mind and shape our character is one of the most tremendous concerns a human being might 
face during dementia. And this is what turns Alzheimer’s disease (AD) into such a tenuous 
matter. People are not just suffering from memory loss and the declining ability to orientate 
themselves in the outside world; they are changing their personality, losing a definition of 
themselves that took a lifetime to develop. Alzheimer’s disease is a global issue with an 
estimated number of 46.8 million people worldwide, living with dementia (Prince 2015). A 
rising life expectancy contributes to the higher prevalence of chronic diseases like dementia. 
Consequently, the incidents of AD are expected to almost double every 20 years (Prince 
2015). Hence, basic research, leading to a better understanding of brain function is 
indispensable to advance our understanding about the disease. This knowledge will ultimately 
lead to the development of effective treatment strategies against AD and dementia. 
1.1. Learning & Memory 
1.1.1. Role of the hippocampus 
The question of where memory formation and storage happens, was discovered in 1957, when 
Scoville and Millner described their patient Henry Gustav Molaison (patient H.M.) that 
received a bilateral resection of the hippocampal formation and adjacent structures (Scoviille 
and Milner 1957). This work and following research revealed the hippocampus to be 
responsible for the formation and recent retrieval of spatial as well as non-spatial forms of 
explicit (declarative) memory (Squire, Stark et al. 2004). Explicit memory comprises 
knowledge of places, facts and events. In contrast, implicit (non-declarative) memory, for 
perceptual and motor skills mostly involves the cerebellum, the striatum and the amygdala 
(Kandel, Dudai et al. 2014). The hippocampal formation is a part of the medial temporal lobe 
(MTL) and consists of the dentate gyrus (DG), the hippocampus, subiculum, presubiculum, 
parasubiculum and entorhinal cortex (EC) (Andersen 2007). It has a unique organization and 
is well conserved among mammals, which allows studies in rodents to be reliable predictors of 
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the human situation (Andersen 2007). The classical trisynaptic circuit starts at the EC, 
representing the major cortical input source to the hippocampus with its strongest connections 
projecting to the DG via the perforant path. The DG granule cells send mossy fibers to CA3, 
from where the Schaffer Collaterals extend to CA1, the main output region of the 
hippocampus. CA1 in turn projects back to the deeper layers of the EC, closing the circuit 
(Knierim 2015) (Fig. 1.1). The hippocampus is thought to be indispensable for memory 
formation, but has a temporally-graded role in storing information (Squire, Stark et al. 2004). 
Initial labile memories are converted into more stable forms during a process termed 
consolidation. This happens on a cellular as well as on a systems level, involving both, changes 
in the connectivity of single cells and brain regions, respectively. Here, cortical regions were 
found to gain in importance whereas the hippocampus became less relevant for the retrieval of 
remote memories (Frankland and Bontempi 2005). The structure and function of all 
hippocampal regions, their excitatory and inhibitory connections and comprising microcircuits 
were intensively studied in the past decades. Today the hippocampus is known to represent a 
spatiotemporal framework for the brain (Knierim 2015). It processes, represents and stores 
high-order information about time and space (Roux and Buzsaki 2015), and provides the 
indispensable distributor of conscious recollection of declarative memories.  
1.1.2. Structure and function of CA1  
CA1 represents the main output region of the hippocampus and has a unique position within 
the hippocampal circuitry receiving multimodal inputs that are compartmentalized between 
the different layers (Spruston 2008). CA3 relays processed information to CA1 basal and 
proximal apical dendrites via Schaffer collaterals (SCs) (Schaffer 1892). Direct cortical input 
on CA1 arrives on the distal apical dendrites in stratum lacunosum moleculare (S-LM) 
originating from layer II of the entorhinal cortex (EC) via the perforant path (PP) (Lopes da 
Silva, Witter et al. 1990) (Fig. 1.1). Derived by its multimodal inputs from EC (direct 
sensory information) and CA3 (mnemonic information), CA1 was ascribed the role of 
comparing current experiences with expectations, based on past experiences (i.e. memory), and 
assess its outcome (Lisman and Otmakhova 2001, Vinogradova 2001, Bittner, Grienberger et 
al. 2015). In case of a mismatch between current and past experience, CA1 was described to 
signal novelty (Knight 1996) characterized by an overall increase of firing and excitability 
within CA1 pyramidal neurons (Lisman and Otmakhova 2001, Larkin, Lykken et al. 2014).  
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Figure 1.1 CA1 within the hippocampal circuitry. The simplified scheme displays the main 
hippocampal excitatory connections. Cortical input from EC layer II innervates DG via PP fibers. MFs connect 
DG with CA3 pyramidal neurons, which then either form an internal loop or project to CA1 pyramidal neurons 
via SCs, targeting basal and proximal apical dendrites, in SO and SR, respectively. CA1 finally relays the 
information to deeper layers of the EC (layer VI) and closes the loop. CA1 additionally receives direct input from 
EC layer III via PP fibers targeting the apical tuft in S-LM. 
Furthermore, the importance of CA1 during learning and memory processes was extensively 
studied. Expanding the results of former lesion studies (Maren, Aharonov et al. 1997), precise 
optogenetic inactivation confirmed the necessity of CA1 for both, acquisition and retrieval of 
recent and remote memories, respectively (Goshen, Brodsky et al. 2011). Nevertheless, the 
brain was able to compensate for CA1 inactivation during retrieval if enough time was given 
(Goshen, Brodsky et al. 2011). Additionally, CA1 features the coding of spatial information. A 
subset of pyramidal neurons, so-called place cells, was shown to fire at specific spatial locations 
(O'Keefe 1971). The specificity of their firing was found to change over time, but increase in 
association with learning processes (Kentros, Hargreaves et al. 1998, Nakazawa, McHugh et 
al. 2004).  
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1.1.3. Neuronal basics of learning & memory 
Learning is the acquisition, memory the retention of information or knowledge (Bear 2007). 
These abilities enable all kinds of creatures that exhibit a nervous system, to adapt to their 
environment. The fundamental principle that forms the basis for learning and the storage of 
information is plasticity (Kandel, Dudai et al. 2014). The idea that memory is the change in 
strength of synaptic connections – the cellular connectionist approach - was born by Ramon y 
Cajal in 1894 (Cajal 1894) and was later named synaptic plasticity (Konorski 1948). Learning 
can be examined in the brain at different levels that are mostly pre-defined by the applied 
techniques: from analysis on the macroscale that focuses on the involvement of different brain 
regions, across mesoscale analysis that deals with connections between different neurons, to the 
point of microscale examinations that analyze changes of single synapses (Ganguly and Poo 
2013). Early research in invertebrates gave rise to the elementary building blocks of learning 
and memory, that were later revealed also in vertebrates, from rodents to the point of humans 
(Kandel, Dudai et al. 2014). One of those building blocks is the discovery of long-term 
potentiation (LTP), a process that enhances the efficacy of synaptic connections in the 
hippocampus due to stimulation of the perforant path to the DG (Bliss and Lomo 1973). A 
concept that was born by Donald O. Hebb in 1949 and that explained the link of two 
neurons as a consequence of their parallel firing (Hebb 1949). This “Hebbian” LTP was later 
also found in CA3 to CA1 synapses (Mayford, Siegelbaum et al. 2012), whereas in mossy fiber 
synapses a non-Hebbian form of LTP was demonstrated that just required presynaptic activity. 
LTP has a brain shaping function as it was shown to influence the size of dendritic spines 
(Matsuzaki, Honkura et al. 2004), small protrusions of the dendritic shaft that carry excitatory 
synapses (Rochefort and Konnerth 2012). Polymerization of the spines’ internal actin 
cytoskeleton, that defines their shape, is closely linked to LTP (Honkura, Matsuzaki et al. 
2008) and synaptic efficacy (Cingolani and Goda 2008). The counterpart of LTP and another 
building block of learning and memory is long-term depression (LTD), a process that 
decreases synaptic efficacy (Ito 2001). The combination of LTP and LTD provides an efficient 
way to specifically strengthen and weaken synaptic connections to tag memory relevant 
neuronal connections and hence, to store memories. The in vivo relevance of both mechanisms 
regarding memory processes was demonstrated by inhibiting and inducing learned behaviors, 
with LTD and LTP, respectively (Nabavi, Fox et al. 2014). Memories have to be divided in at 
least two different forms regarding their age: short-term memory is believed to rely on changes 
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in strength of existing synapses, whereas long-term memory storage is thought to involve 
structural changes and thus, the loss or gain of synaptic connections, termed structural 
plasticity (Bailey and Kandel 1993). Differences in the nature of a memory are predetermined 
by the kinetics of underlying molecular changes, whose structural influence dictates the 
information flow that finally triggers an behaviorally relevant output (Mayford, Siegelbaum et 
al. 2012). 
1.1.4. Functions of inhibitory interneurons 
The activity of excitatory principal neurons is driven by excitatory input and is precisely 
modulated by inhibitory interneurons (Basu, Srinivas et al. 2013). At least two major types of 
inhibition can be distinguished: feed-forward and feed-back inhibition (Buzsaki 1984). The 
former describes external excitatory input on interneurons that in turn inhibit local principal 
cells that might additionally receive the external excitatory input. Feed-back inhibition 
describes the excitation of interneurons that in turn inhibit the source of excitation. These and 
related forms of inhibition are principles that do not correspond to specific interneuron types 
and are furthermore, not mutually exclusive (Roux and Buzsaki 2015). Interneurons can be 
distinguished by their specific target on the principal cell, ranging from somata (basket cells), 
over axon initial segments (chandelier or axo-axonic cells) to dendrites (Roux and Buzsaki 
2015). In CA1 a subclass of dendrite-targeting interneurons was shown to be involved in the 
compartmentalization of inputs to CA1 during contextual fear conditioning (Lovett-Barron, 
Kaifosh et al. 2014). Both contextual information and aversive stimulus evoked inputs reach 
the hippocampus at the distal dendrites of CA1 pyramidal neurons. Somatostatin 
(SOM)-positive interneurons inhibit the simultaneously arriving aversive information during 
cFC and thus, allow the processing of contextual information by the hippocampus. Inhibition 
of SOM-positive interneurons during learning impaired memory retrieval, demonstrating the 
indispensability of this interneuron type. Structural plasticity of inhibitory interneurons plays 
a major role during learning and memory processes, as its impairment on SOM-positive 
interneurons was associated with memory deficits in a mouse model of Alzheimer’s disease 
(Schmid, Mittag et al. 2016). Furthermore, increased feed-forward inhibitory connectivity at 
DG to CA3 synapses was shown to regulate memory precision (Ruediger, Vittori et al. 2011). 
Another class of interneurons, i.e. parvalbumin (PV)-expressing (PV+) soma-targeting neurons, 
was shown to be differentially modulated by learning, dependent on the type of the learning 
task (Donato, Rompani et al. 2013). The increase in feed-forward inhibition was revealed to 
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correlate with learning and hence, suggested to be a general mechanism of learning in 
hippocampal and cerebellar circuits (Caroni 2015).  
1.1.5. The engram hypothesis 
More than 100 years ago, the German scientist Richard Semon introduced his idea that 
experience leaves a footprint in the brain, a physical substrate of memory, called “the engram”, 
which later can be recalled from a dormant state to a state of manifested activity, a process 
called “ecphory” (Semon 1921). The idea was picked up and experimentally corroborated by 
Lashley. He focused his research on finding the location of the memory trace in specific brain 
areas (Josselyn, Köhler et al. 2015). Although most experimental approaches attempted to find 
memory traces in one particular region, it was self-evident that the trace manifests in various 
interconnected brain regions, dependent on the type of memory. The learning-dependent 
changes were analyzed in different dimensions, from micro- to macro-scale. The micro-scale 
readout described changes on the synaptic level, including structural and functional properties 
of synapses. These changes directly determine the strength of connections between neurons 
and thus, their participation in storing information on the macro-scale. It is assumed that 
learning involves in part the same neuronal population that participates in retrieving the 
memory (Schacter, Curran et al. 1999, Frankland and Bontempi 2005). However, there is an 
ongoing debate concerning the size of the reactivated neuronal ensemble (Josselyn, Köhler et 
al. 2015). Further research aimed at identifying the underlying molecular processes of memory 
formation and revealed that neurons are recruited to encode a memory based on their 
excitability immediately before training (Yiu, Mercaldo et al. 2014). In addition, it is 
important to mention that the idea of an engram indeed refers to a static memory trace. 
However, early ideas hypothesized and recent research revealed the dynamics of a memory 
trace (Nadel 2007). Retrieval can thus lead to an update of stored memories by a process 
named reconsolidation (Rodriguez-Ortiz and Bermudez-Rattoni 2007). Evolving technologies, 
e.g. the use of activity-dependent promoters, cre/loxP-expression systems, optogenetics and 
pharmacogenetics, together with accumulating knowledge allowed to label and to manipulate 
neuronal subsets, being part of a memory. Thus, it was shown for hippocampal CA1 and 
several other brain regions that artificially activating or inactivating neurons that participated 
in learning was sufficient for behaviorally retrieving or repressing a memory (Goshen, Brodsky 
et al. 2011, Garner, Rowland et al. 2012, Ramirez, Liu et al. 2013, Cowansage, Shuman et al. 
2014, Kim, Kwon et al. 2014). Although the term “engram” was born 100 years ago, it 
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survived and was adapted to the current knowledge about experience-dependent changes in 
the nervous system on different scales. It comprises functionally interconnected groups of 
neurons, whose activity manage to implement a corresponding behavioral output (Holtmaat 
and Caroni 2016). 
1.1.6. Fos as a marker for neuronal activity 
Many different approaches exist to examine the activity of neurons that mainly differ in the 
number of captured neurons and temporal resolution. In addition to classical 
electrophysiological methods to record neuronal activity, the development of optical methods 
in combination with genetically encoded calcium indicators (GECIs) generated more and 
more interest, as it allowed the analysis of large neuronal populations with a high spatial and 
temporal resolution on the millisecond to second time-scale. In parallel, approaches like the 
expression of immediate early genes (IEGs) were refined that integrate neuronal activity over 
minutes and hours. After neuronal activity IEGs are the first fast and transiently transcribed 
genes. They connect incoming external signals to intracellular signaling cascades and are 
important regulators of gene expression (Sheng and Greenberg 1990). IEGs can be 
functionally categorized into two classes: IEGs that code for regulatory transcription factors 
(e.g. c-fos, c-jun and zif268) that effect the transcription of other genes, and effector IEGs (e.g. 
Arc, Homer 1) that directly influence cellular function (Lanahan and Worley 1998, Kubik, 
Miyashita et al. 2007). Due to their fast and activity-dependent expression they have been 
used as a marker for recent neuronal activity since 1988. Here, Sagar et al. first described an 
immunohistochemical approach for labeling Fos (FBJ osteosarcoma oncogene) protein and 
thereby enabling the post-mortem analysis of neuronal subsets that had been recently activated 
(Sagar, Sharp et al. 1988). Since then c-fos mRNA and Fos protein have been applied in many 
studies as approximation for neuronal activation (Curran 1991). Later, Guzowski et al. 
advanced the IEG research field with establishing a method called cellular compartment 
analysis of temporal activity by fluorescence in situ hybridization (catFISH) (Guzowski, 
McNaughton et al. 1999). Here, the time-dependent localization of Arc mRNA allowed for 
repeated observation of the same neuronal ensembles within the same subject responding to 
two separate events. This conventional post-mortem IEG analysis is a reliable indicator of 
recent activity. However, IEG analysis just allows the measurement of events separated by 
minutes to hours (Kubik, Miyashita et al. 2007). This characteristic excludes the analysis of 
long-term memory storage in the same neuronal ensembles. The usage of IEG promoters for 
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driving various expression systems that allow for experience-dependent tagging revolutionized 
the field and enabled the analysis and manipulation of neuronal populations participating in 
learning and memory. The development of IEG-reporter mouse models (Reijmers, Perkins et 
al. 2007, Eguchi and Yamaguchi 2009, Tayler, Lowry et al. 2011) and the parallel progress in 
in vivo imaging approaches that allowed for deep tissue penetration (Helmchen and Denk 
2005, Svoboda and Yasuda 2006) opened further possibilities to monitor neuronal ensembles 
of recently active neurons, repetitively for periods of weeks or even months (Schoenenberger, 
Gerosa et al. 2009, Cruz, Koya et al. 2013, Tayler, Tanaka et al. 2013, Jouhanneau, Ferrarese 
et al. 2014). In 2004, the fosGFP mouse model utilized in the present study was developed. 
The mouse expresses the enhanced green fluorescent protein (eGFP) under the c-fos promoter 
and hence, allows for visualization of recent neuronal activity (Barth, Gerkin et al. 2004). The 
expressed transgene generates a fosGFP fusion protein preserving the biological function of 
Fos (Barth, Gerkin et al. 2004). It was shown to be involved in the induction of LTP at CA1-
CA3 synapses and necessary for spatial and associative learning tasks (Fleischmann, Hvalby et 
al. 2003), as well as memory consolidation (Guzowski and McGaugh 1997). Endogenous c-fos 
expression is triggered by activity-mediated influx of Ca2+ through voltage-gated calcium 
channels (Morgan and Curran 1986) that subsequently activates the extracellular signal-
regulated kinase (ERK)/mitogen-activated protein kinase (MAPK)-dependent phosphorylation 
of transcription factors, which in turn bind to the c-fos promoter (Cohen and Greenberg 2008) 
(Fig. 1.2). Hence, the resulting c-fos expression is a summation of Ca2+ events inside a 
neuron. 
 
Figure 1.2 Activation of the c-fos promoter in fosGFP mice. Neuronal activity leads to the opening of 
N-methyl-D-aspartate (NMDA) receptors and voltage-gated calcium channels (VGCCs) that allow the influx of 
calcium (Ca2+) into the intracellular space (light blue). Increasing calcium levels trigger the phosphorylation of 
extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) that subsequently 
phosphorylates transcription factors (TFs) that then start expression of c-fos and a fused enhanced green 
fluorescent protein (eGFP). Modified according to Box2 in (Cruz, Koya et al. 2013). 
  1 INTRODUCTION 
 9 
It was hypothesized that only strong and consistent activity in a certain time frame elicits 
expression (Cruz, Koya et al. 2013). Indeed, electrophysiological characterization of fosGFP 
expressing neurons in layer 2/3 of the primary sensory cortex possessed a higher firing rate 
than fosGFP-negative neurons (Yassin, Benedetti et al. 2010). 
1.2. Alzheimer’s disease 
1.2.1. Brief history and mechanisms of AD 
In 1906, when the German physician Alois Alzheimer first described a “peculiar” disease with 
abnormal deposits in and around neurons and a profound shrinkage of the brain structure, he 
was a pioneer in bridging microscopic methods and clinical interest in patients to gain causal 
links between pathology and clinical symptoms (Hippius and Neundorfer 2003). Emil 
Kraepelin first named this disease after his colleague in 1910 (Hippius and Neundorfer 2003). 
It took almost another seventy years before Alzheimer’s disease was recognized as the most 
common form of dementia by the neurologist Robert Katzman in 1976 (Katzman 1976) and 
even eight years more until the first hallmark of AD, amyloid-β (Aβ), was identified by George 
Glenner and Cai'ne Wong in 1984 (Glenner and Wong 1984). In 1986, just two years later 
the second hallmark, neurofibrillary tangles (NFTs), was described to largely consist of the 
microtubule-associated hyperphosphorylated protein tau (Grundke-Iqbal, Iqbal et al. 1986). 
Since then, research accelerated. Today, it is known that Aβ derives from a larger protein, 
consequentially named amyloid precursor protein (APP) and that multiple Aβ species can arise 
depending on the participating cleavage enzyme (Weidemann, Konig et al. 1989). The 
proteolytic cleavage of APP is occurring in two different ways: the non-amyloidogenic pathway 
is initiated by the α-secretase and leads to several soluble protein fragments (Van Dam and De 
Deyn 2006). The amyloidogenic pathway describes the cleavage by β-site APP cleaving 
enzyme 1 (BACE-1), also named β-secretase that produces a soluble N-terminal fragment and 
an amyloidogenic C-terminal fragment (Vassar, Bennett et al. 1999). The latter is further 
processed by the γ-secretase complex, containing presinilin-1 (PSEN1), leading to an 
intracellular APP domain (LaFerla, Green et al. 2007) and soluble Aβ-monomers (Van Dam 
and De Deyn 2006) (Fig. 1.3). Here, several variants differing in their self-aggregating 
potential arise, namely Aβ42, Aβ40 and Aβ38, whereas the former is more prone to aggregate 
in vitro and in vivo (Jarrett, Berger et al. 1993, Haass and Selkoe 2007) and represents the  
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Figure 1.3 Processing of APP.  The amyloid precursor protein (APP) is a membrane bound protein and can 
be processed via the non-amyloidogenic and the amyloidogenic pathway, resulting in soluble or insoluble species 
of APP fragments, respectively. α-, β- and γ-secretases cleave APP at different target sites resulting in fragments 
with distinct aggregation properties. The toxic species that is related to AD is generated by β- and γ-secretase 
cleavage, resulting in amyloid-β. APP-CTF, APP C-terminal fragment; APP-NFT, APP N-terminal fragment. 
Modified according to Figure 1 in (LaFerla, Green et al. 2007). 
major variant that was found in the brains of AD patients (Iwatsubo, Odaka et al. 1994). 
Aβ-monomers alone do not define the pathology, as it is also found in the cerebrospinal fluid 
of non-diseased human individuals (Shull, Heintz et al. 1991, Seubert, Vigo-Pelfrey et al. 
1992). In AD, the production of the highly amyloidogenic form of Aβ, i.e. Aβ42, lead to its 
aggregation into oligomers that causes synaptic dysfunction (Haass and Selkoe 2007), and to 
the formation of long, insoluble fibrils that constitute the “spherical microscopic deposits”, 
known as Aβ plaques (Haass and Selkoe 2007). Oligomeric Aβ species isolated from post-
mortem brain tissue of AD patients were found to correlate with memory loss (Gong, Chang 
et al. 2003). Their toxicity becomes manifested in causing calcium dyshomeostasis (LaFerla 
2002), inhibiting the induction (Shankar, Li et al. 2008) and affecting the maintenance of 
hippocampal LTP (Walsh, Klyubin et al. 2002) and lowering the threshold for LTD (Shankar, 
Li et al. 2008). Furthermore, Aβ-oligomers were demonstrated to reduce 
N-methyl-D-aspartate (NMDA) receptor-evoked currents and therefore cause synaptic failure 
(Selkoe 2002, Snyder, Nong et al. 2005). This and further molecular and functional 
implications lead to synaptic dysfunction, shrinkage and loss (Koffie, Hashimoto et al. 2012). 
The increasing collapse of synapses results in neuronal network dysfunction that furthermore 
accounts for cognitive decline (Verret, Mann et al. 2012). In human AD patients, an Aβ-
mediated reduction in neuronal activity was shown, as their cortical and hippocampal brain 
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regions appeared hypometabolic in a positron emission tomography (PET) (Johnson, Fox et 
al. 2012). However, clinical observations detected also a high incidence of epileptic seizures in 
AD patients (Palop and Mucke 2009), hinting rather at hyper- than hypoactivity. This was 
further demonstrated by observing individual hyperactive neurons in the direct vicinity (< 60 
µm) of Aβ plaques in the cortex (Busche, Eichhoff et al. 2008) and hippocampus (Busche, 
Chen et al. 2012) of transgenic AD mice in vivo. The second hallmark of AD, intracellular 
NFTs, are consistently found in the brains of AD patients (Braak and Braak 1991). Aberrant 
phosphorylation of the microtubule-associated protein (MAP) tau lead to its aggregation into 
paired helical fragments, to then form NFTs (Buee, Bussiere et al. 2000). The aggregation 
prevents tau to follow its biological functions in guaranteeing axonal transport by stabilizing 
microtubules and hence contributes to synaptic dysfunction and neuronal death (Roy, Zhang 
et al. 2005). Synapse loss and concomitant neuroinflammation are events that precede the 
formation of NFTs and are mainly caused by a loss-of-function due tau hyperphosphorylation 
(Ballatore, Lee et al. 2007). There is an ongoing debate whether and how Aβ and tau 
abnormalities are linked and which presents the origin of disease (Small and Duff 2008). 
However, both pathologies are found in the brains of AD patients postmortem and together 
led to profound neuronal loss that is causing inflammation, brain shrinkage and associated 
symptoms (Small and Duff 2008). 
1.2.2. Genetic mutations linked with AD 
Mutations in the genes coding for human APP (Goate, Chartier-Harlin et al. 1991), PSEN1 
or presenilin 2 (PSEN2), an homologue of PSEN1, are linked to autosomal-dominant early-
onset AD (EOAD) and cause an increase in Aβ through favoring the amyloidogenic 
processing of APP (Palop and Mucke 2010). Mutations within the Aβ domain of the APP 
conding gene even lead to enhanced oligomerization (Haass 2004). EOAD accounts for about 
1% of AD cases (Hardy 1997, Van Cauwenberghe, Van Broeckhoven et al. 2016), whereas 
late-onset AD (LOAD) starting at an age of 65 years and older represents the most common 
form (Small and Duff 2008). Here, a variant of the apolipoprotein E (APOE) named APOE 
ε4 is known to increase the risk of developing LOAD (Corder, Saunders et al. 1993). Both 
forms of AD are usually indistinguishable in their clinical and histopathological phenotype, 
with the biggest difference being the age of onset (Selkoe 2002). Genome-wide association 
studies (GWAS) and massive parallel resequencing (MPR) approaches identified around 20 
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additional loci in the human genome that increase the risk for developing AD (Van 
Cauwenberghe, Van Broeckhoven et al. 2016). The location of these genes gave rise to the 
involvement of lipid metabolism, inflammatory responses and endosomal vesicle trafficking 
and hence, shed light on the genetic complexity of the disease (Van Cauwenberghe, Van 
Broeckhoven et al. 2016). The multifactorial nature of AD impedes the development of 
effective disease-modifying treatments. However, genetic profiling is a powerful tool for 
prediction and prevention of this devastating disease (Van Cauwenberghe, Van Broeckhoven 
et al. 2016). 
1.2.3. Mouse models for studying AD 
Today it is known that the disease is a complex interplay of Aβ and tau pathologies, that 
themselves interact with many other molecules and signaling cascades leading to a broad 
influence on the neuronal network (Mucke 2009). Most existing mouse models do not mimic 
the complete facets of the complex disease. However, important aspects have been successfully 
recapitulated and helped already to develop treatment strategies and support preclinical trials 
(LaFerla and Green 2012). For this purpose, several isomorphic disease models that 
concentrate on the involvement of selected pathologies on the development and progression of 
AD, have been developed. Before the first transgenic mouse was developed in 1991, AD was 
and still is mimicked by infusing Aβ peptides of various length into the brain tissue of mice 
(Harkany, O'Mahony et al. 1998, Yamada, Chiba et al. 2005, Van Dam and De Deyn 2006). 
Transgenic mouse models of amyloidosis as PDAPP (Games, Adams et al. 1995), Tg2576 
(Hsiao, Chapman et al. 1996) and APP23 (Sturchler-Pierrat, Abramowski et al. 1997) express 
APP carrying different identified mutations and utilizing diverse promoters. In 2004 
Jankowsky et al. developed a transgenic mouse with humanized mouse APP carrying the 
Swedish mutation (K670N, M671L) (Mullan, Crawford et al. 1992) and a mutant PS1 that 
both led to an increase in Aβ42 levels, characteristic for the brains of AD patients (Jankowsky, 
Fadale et al. 2004). Later, transgenic mice that additionally exhibit tauopathies were 
developed. These exhibit increased amyloid deposits, formation of NFTs and an overt loss of 
neurons (Gotz, Schild et al. 2004). Today, several mouse models vary in their validity that is 
defined by the degree the animal resembles the human condition in aetiology, 
pathophysiology and symptomatology and legitimate their importance for pre-clinical drug 
trials (Van Dam and De Deyn 2006). However, most animal models focus on single aspects of 
the disease (Van Dam and De Deyn 2006). This requires careful attention to prevent 
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neglecting other pathological features. In fact, a simplification of complexity is rather helpful 
for basic research that aims at understanding the involvement of each identified pathological 
feature during onset and disease progression (Palop, Chin et al. 2006, Radde, Duma et al. 
2008). 
1.2.4. Treatment strategies 
The need to tackle Alzheimer’s disease with disease-modifying treatments will become stronger 
with our aging society. Current treatment strategies target either the cholinergic or the 
glutamatergic metabolism, since both are largely compromised by the disease (Cummings 
2004). Cholinesterase inhibitors enhance neurotransmission by inhibiting the 
neurotransmitter degrading enzyme acetylcholinesterase (AchE). NMDAR antagonists reduce 
cell death by preventing excessive glutamate release. However, these approaches just improve 
symptoms, in a transient and moderate fashion (Huang and Mucke 2012). The genetic 
identification of mutations in APP (Goate, Chartier-Harlin et al. 1991), PSEN1 and PSEN2 
(Sherrington, Rogaev et al. 1995), led to an Aβ centric view of estimating the origin of the 
disease. The amyloid hypothesis describes Aβ as main driver of pathology, causing tau 
hyperphosphorylation and further disease associated phenotypes, like calcium dyshomeostasis 
(LaFerla 2002) and synaptic dysfunction. Hence, treatment strategies focused on either 
decreasing Aβ production, reducing its aggregation or increasing Aβ clearance. Promising 
strategies represent the inhibition and modulation of APP processing enzymes, i.e. β- and γ-
secretase (De Strooper, Vassar et al. 2010) that aim at reducing the amyloidogenic processing 
of APP. However, prevailing challenges are the reduction of side effects by enhancing the 
specificity of inhibitors to APP processing secretases and overcoming the blood brain barrier 
(BBB) (Huang and Mucke 2012). Unfortunately, phase III trials with secretase blockers failed 
due to worsening of cognitive impairments (Schor 2011) or inefficiency (Huang and Mucke 
2012). Aβ clearing was targeted via active or passive immunization using Aβ-peptides or anti-
Aβ42 antibodies, respectively (Wisniewski and Konietzko 2008). Immunopathological side 
effects stopped the active immunization approach (Gilman, Koller et al. 2005), however, 
passive immunization approaches reached phase III and are still ongoing. Furthermore, drugs 
targeting the second hallmark of AD, i.e. neurofibrillary tangles (NFTs), were developed. As 
NFTs are composed of the microtubule-stabilizing protein tau, treatment approaches aim at 
reducing tau levels, its aggregation or phosphorylation. Additionally, microtubule-stabilizing 
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drugs have been a valuable tool to prevent axonal transport impairments and the concomitant 
neuronal loss (Trojanowski, Smith et al. 2005). Besides challenges regarding BBB penetration 
and drug specificity, an underestimated matter is the composition of the phase III treated 
group of humans. Most of the patients enrolled in these trials already exceeded the pre-
symptomatic stage. Hence, their treatment will not be suited to assess the ameliorating 
properties of treatments aiming at preventing AD in the pre-symptomatic stage (Huang and 
Mucke 2012). The complexity of the disease with its tight enmeshment with the general 
health status of human individuals (Huang and Mucke 2012) suggests a combined therapy as 
potential solution (Huang and Mucke 2012). Although more than ten approaches failed in 
phase III, careful optimism can be spread, as a lot more potential drugs entered clinical trials.  
1.3. Aim of the study 
Basic research is indispensable to further shed light on mechanisms underlying Alzheimer’s 
disease (AD) and hence, to provide targets for the development of efficient treatment 
strategies. The hippocampus is one of the first regions affected by the disease and 
indispensable for learning and memory processes that are considerably affected in AD. The 
current study has two main goals: First, finding cellular and synaptic correlates of learning and 
memory that manifest in the hippocampus. Second, identifying alterations induced by 
pathology in a preclinical model of Alzheimer’s disease (APP/PS1 mice). On the cellular level, 
the CA1 neuronal population participating in learning and retrieval will be examined, to 
define the size and characteristics of the memory encoding neurons – the so-called engram. It 
is known that neuronal firing is strictly regulated by inhibitory neurons. Therefore, the 
importance of PV+ interneurons for learning and memory will be assessed. Moreover, 
structural changes of excitatory neurons on the level of dendritic spines that potentially relate 
to memory will be investigated. To tackle these questions, the current study will utilize two-
photon in vivo imaging to repetitively monitor the same neuronal populations and will 
furthermore apply neuronal cell type-specific manipulation methods in healthy and APP/PS1 
mice, respectively. Based on the cellular and structural findings in healthy mice, this study 
aims at elucidating whether the memory impairment in APP/PS1 mice is due to altered 
memory formation or a deficiency in retrieval. 
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2. METHODS 
2.1. Transgenic mice 
B6.Cg-Tg(Fos/EGFP)1-3Brth/J mice (Barth, Gerkin et al. 2004) (Stock number: 014135, 
The Jackson Laboratory) carry a fusion transgene consisting of the murine 
FBJ (Finkel-Biskis-Jinkins) osteosarcoma oncogene (Fos) and enhanced green fluorescent 
protein (eGFP). The eGFP was fused to the c-terminus of the Fos gene, leaving the function of 
Fos intact. Throughout the text mice will be referred to as fosGFP mice. 
B6.Cg-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax (APP/PS1) double transgenic mice 
(Jankowsky, Fadale et al. 2004) (MMRRC Stock No: 34832-JAX) express a chimeric 
human/mouse amyloid precursor protein (Mo/HuAPP695swe) under the mouse prion protein 
promoter and a mutant PS1 with a deletion of exon 9 (PS1-dE9). Both, the Swedish mutation 
in APP and the PS1 mutant led to increased Aβ42 levels. Mice were crossbred with fosGFP 
mice. Offspring carrying both transgenes will be referred to as APP/PS1 mice, whereas mice 
just carrying the fosGFP transgene will be named wild-type mice throughout the text. 
Furthermore, APP/PS1 mice will additionally be referred to as mouse model of Alzheimer’s 
disease (AD), aware of the fact that it mimics not every aspect of the disease. Experiments were 
carried out at an age of 13-18 months. Slc17a6tm2(cre)Lowl/J (Vglut2-ires-cre) mice (Stock 
number: 016963, The Jacksons Laboratory) were on a 129S4 background and 6-8 months of 
age. C57BL/6J mice (Stock number: 000664, The Jacksons Laboratory) were four month of 
age. B6.129P2-Pvalbtm1(cre)Arbr/J mice (Stock number: 008069, The Jacksons Laboratory) 
express Cre recombinase in parvalbumin-expressing (PV+) interneurons, without disrupting 
endogenous PV expression (Hippenmeyer, Vrieseling et al. 2005). Mice were backcrossed to 
C57BL/6J background and referred to as PV-Cre mice throughout the text. Experiments were 
carried out at an age of 19-21 months. B6.Cg-Tg(Thy1-YFP)HJrs/J (YFP-H) mice (Stock 
number: 003782) were crossbred with APP/PS1 mice. Offspring carrying both transgenes will 
be referred to as APP/PS1 mice, whereas mice just carrying the YFP-H transgene will be 
named wild-type mice throughout the text. All animals were housed with a 12/12 light/dark 
cycle under specific pathogen-free (SPF) conditions in individually ventilated cages (IVCs), 
either alone or in groups of 2 to 5 mice, separated by gender. Temperature and relative 
humidity were kept constant (22°C, 40 % RH). Food and water was available ad libitum.   
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2.2. Adeno-associated virus (AAV) injection 
Mice were anesthetized with an intraperitoneal (i.p.) injection of ketamine (0.13 mg/g 
bodyweight, Ketavet®) and xylazine (0.01 mg/g bodyweight, Rompun®). The head was wiped 
with 70% ethanol using sterile collection swabs (EUROTUBO®) before a small incision was 
made right above the midline ranging approximately from bregma to lambda. The periosteum 
was carefully pushed aside and coordinates of interest were marked. For optogenetic 
manipulation of CA1 neurons the virus was delivered to the hippocampus without damaging 
the pyramidal layer (AP: -1.9 mm, ML: ±1.5 mm, DV: -1.0 mm (from brain surface)). For 
pharmacogenetic experiments the focus was set at achieving a broad, but exclusive infection of 
CA1 neurons (AP: -1.85 mm, ML: ±1.5 mm, DV: -1.10 mm (from brain surface)). The holes 
were drilled and the dura mater was incised. Then the tip of the needle was slowly lowered to 
the depth of interest and the appropriate volume of AAV (AAV1-EF1a-DIO-eNpHR-eYFP-
WPRE-hGH and AAV2-FLEX-tdTomato, 1µl/hemisphere; AAV2-hSyn-DIO-hM3D(Gq)-
mCherry, 0.5 µl/hemisphere; AAV2/1-Fos-tTA + AAV2/1-PTRE-tight-hM3D(Gq)-mCherry 
(1:2), 0.5µl/hemisphere) was injected with a speed of 100 nl/minute. After injection the 
needle was left in place for another 5 minutes to let the virus diffuse into the tissue. This 
procedure was repeated at the contralateral injection side. Finally, the wound was properly 
stitched and disinfected with povidon-iodine (Betaisodona®). During the next three days mice 
were monitored and received a post-surgery treatment with buprenorphine (Temgesic®). Mice 
were allowed to recover from surgery for at least two weeks. 
2.3. Cranial hippocampal window 
Mice were deeply anesthetized with an intraperitoneal (i.p.) injection of ketamine (0.13 mg/g 
bodyweight, Ketavet®) and xylazine (0.01 mg/g bodyweight, Rompun®). Additionally, an 
analgesic (0.05 mg/kg bodyweight, buprenorphine, Temgesic®), an antibiotic (0.25 mg/g 
bodyweight, cefotaxim) and an immunosuppressant drug (0.2 µg/g bodyweight, 
Dexamethasone 21-phosphate disodium salt) were applied subcutaneously (s.c.) before 
surgery. Eyes were covered with eye ointment (Bepanthen®) to prevent drying. After 
confirming a deep anesthesia with testing the paw pinch withdrawal reflex, the mouse head 
was wiped with 70% ethanol using sterile collection swabs (EUROTUBO®), to clean and 
disinfect the spot of surgery. A triangular skin cut was made to expose the skull. The trimmed 
sites of the skin were rinsed with 0.9% NaCl and cleaned from excess hair before the 
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periosteum covering the exposed bone was carefully removed with a scalpel. To prepare the 
bone for the first layer of glue serving as a ground coat, Gel Etchant (OptiBond™ FL bottle 
kit) was spread across the bone for 15 seconds, before it was removed by thoroughly rinsing 
the bone with 0.9% NaCl. The bone was then dried by carefully applying compressed air. 
After complete drying of the bone (crucial step!), light-curing glue was subsequently applied in 
a two-step procedure (OptiBond™ FL bottle kit). First, the “Primer” was distributed and air-
dried for five seconds. Second, the “Adhesive” was applied, air-thinned for five seconds and 
then dried by blue light (420-480 nm) using light-curing device. Next, a circle (∅ 3mm) was 
marked on the right hemisphere above the hippocampal formation (center coordinates, 
AP: -1.90 mm, ML: +2.10 mm) using a biopsy punch (Fig. 2.1a). A dental drill was used to 
cut out this circular bone piece. The dura mater was removed using fine forceps, before the 
cortical tissue above the hippocampus was aspirated. This was achieved by using a blunt needle 
(gauge 21) connected via flexible thick-walled tubing to a vacuum pump. As soon as the 
axonal fibers of the external capsule were reached, which can be easily distinguished by eye 
from the above lying cortical tissue (Fig. 2.1b), the needle size was decreased to gauge 27 to 
allow a more precise control of the aspirated volume. The external capsule of the hippocampus 
was carefully peeled away, exposing the fibers of the underlying alveus that was kept intact 
(Fig. 2.1b). As soon as the depth of interest was reached the blood flow was stopped with an 
absorbable gelatin sponge (GELITA-SPON®). The exposed brain was rinsed with 0.9% NaCl 
before the sterilized hippocampal window consisting of a stainless-steel tube, closed on one 
 
Figure 2.1 Hippocampal window. (a) Scheme showing the position of the hippocampal window (∅ 3mm, 
red dashed circle) on top of the mouse’ skull. (b) Schematic representation of the exposed brain tissue during the 
aspiration procedure. Superficial (1) and deep (2) cortical layers as well as the fibers of the external capsule (3) 
and alveus (4) with their depth-dependent orientation can be distinguished by eye. (c) Top and side view of the 
fixation bar without and with attached stainless-steel cylinder, respectively. Blue, cover glass; numbers depict mm. 
(d) Scheme of an implanted hippocampal window. (e) Fixation of the mouse head during imaging in anesthesia. 
A heating pad maintains the body temperature. 
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side by a cover glass, and a fixation bar (Fig. 2.1c) was lowered into the cavity, orienting the 
fixation bar to the front of the mouse head (Fig. 2.1d). While gently pressing and holding 
the headpiece in place, all excessive liquid was removed from the bone until it was completely 
dry (crucial step!). Then the headpiece was fixed with liquid instant glue, thereby sealing the 
gap between bone and metal completely. Finally, a light-cured flowable composite 
(GRADIA® DIRECT Flo) was spread all across the exposed bone, surrounding the headpiece 
and fixing it to the skull. Blue light was applied for at least 30 seconds to cure the composite. 
Mice were released from the fixation frame (custom build) and kept separate and warm until 
complete recovery from anesthesia. Mice were under surveillance for at least three days, 
received post-surgery applications of analgesic and antibiotics, and were monitored 
thoroughly. 
2.4. Optical fiber implantation 
Mice were anesthetized with an i.p. injection of ketamine (0.13 mg/g bodyweight, Ketavet®) 
and xylazine (0.01 mg/g bodyweight, Rompun®). The head was wiped with 70% ethanol 
before a triangular skin cut was made to expose the skull. The periosteum was removed and 
the underlying bone was dried properly. The skull was roughened with a scalpel and covered 
with a liquid instant adhesive. Two holes were drilled at the sites of previous injections using a 
dental drill. After ensuring that the dura was opened by an incision (crucial!) the two-ferrule 
cannula was carefully lowered to a depth of 1 mm by using micromanipulators (LN Junior 
RE/LE, 3 axes). Cement (Cyano Veneer® Pulver and Cyano Fast) was applied until the 
cannulas were fixed to the skull. The exposed bone was additionally covered with cement to 
increase the stability of the composition. Mice were released from the fixation frame and kept 
separate and warm until complete recovery from anesthesia. Mice were under surveillance for 
at least three days, received post-surgery applications of analgesic and were monitored 
thoroughly. 
2.5. Behavioral experiments 
2.5.1. Handling 
Mice were accustomed to the handling by the experimenter on two consecutive days before the 
actual experiment started. For this purpose, mice were grabbed at the most proximal part of 
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their tail and placed on the palm for ∼15 seconds before they were placed back into their cage. 
This procedure was repeated four times with a spacing of ∼2 minutes. Handling was carried 
out at the same time of day as the upcoming experiments. Transportation from the animal 
holding to the experimental room was also included in the handling procedure. For 
experiments involving optical stimulation, the light fiber attachment procedure including 
freely movement with attached light fiber was included within the handling procedure. 
2.5.2. Contextual fear conditioning 
For contextual fear conditioning, mice were allowed to explore the conditioning chamber 
(context A) for two minutes (pre-shock) before the first electric shock was applied (S#1, 0.75 
mA, 2 seconds), followed by two additional shocks (S#2 and S#3), separated by 60 seconds. 60 
seconds after the last shock, mice were returned to their home cage (Fig. 2.2a). 48 hours 
after the conditioning, mice were either placed back into context A or a novel context B for 
five minutes (test) (Fig. 2.2b). Mice were video recorded from above throughout the 
experiment using a camcorder or a webcam. Videos were analyzed post-hoc by an 
experimenter blind to the experimental conditions using the software EthoVision XT (see 
section 2.5.4). Context A was a rectangular chamber (21.5 cm x 20.0 cm x 40.0 cm) 
consisting of four transparent acrylic glass walls (Fig. 2.2c). The floor was composed of a 
metal grid, connected to a stand alone shocker/scrambler.  
 
Figure 2.2 Behavioral setups. (a) Timeline for contextual fear conditioning (cFC): after 120 seconds 
exploration (pre-shock), three shocks were applied (S#1-S#3) with a duration of two seconds (yellow). Pre-shock 
interval: 120 seconds; inter-shock intervals S1, S2 and S3: 60 seconds. (b) Timeline for contextual fear memory 
test. (c-e) Pictures showing the fear conditioning chamber (context A, c),  the novel context B (d) and the open 
field box (e) from above. Sizes of the boxes’ floors are: 21.5 cm x 20 cm (c), 21 cm x 21 cm (d) and 25 cm x 25 
cm (e). The height was 40 cm for all boxes. 
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Light conditions were kept constant. Before and after every single session, the chamber was 
wiped with 70% ethanol. Context B was placed in a different room than context A, consisted 
of four red transparent acrylic glass walls (21.0 cm x 21.0 cm x 40.0 cm) and a white soft 
plastic floor (Fig. 2.2d). The light conditions for context B were darker than for context A. 
Here, the chamber was wiped out with hygienic paper before and after every single session. 
2.5.3. Open field test (OFT) 
The rectangular open field box (25 cm x 25 cm x 40 cm) was made of white medium density 
fiberboard plates with an open top (Fig. 2.2e). Preceding the behavioral testing the box was 
wiped with 70% ethanol. Fiber-attached mice (see section 2.6.1) were placed in the middle of 
the box and were given ten minutes to explore the box during light stimulation. Subsequently, 
mice were placed back into their home cage. Mice were video monitored during exploration 
using a camcorder. 
2.5.4. Behavior analysis 
For every behavior analysis EthoVision XT was utilized for post-hoc video analysis and 
behavioral scoring. The travelled distance was scored automatically. Freezing, used as a readout 
for learned fear (Blanchard and Blanchard 1969), was defined as the complete absence of 
movement, except for breathing (De Oca, DeCola et al. 1998) and was scored manually and 
blind to the experimental conditions. The time freezing was depicted as percentage to the total 
time analyzed (see section 6.2.4).  
2.6. Behavior manipulation 
2.6.1. Light stimulation via optical fibers 
Animals with implanted cannulas (see Fig. 3.7b) were attached to long flexible fibers via a 
magnetic mechanism. Both fibers are connected to the light sources via a rotary joint that 
allowed the attached animals to freely move within the behavioral setup. During the 
stimulation periods (light ON), mice received continuous light stimulation at 594 nm 
(~20 mW). 
  
  2 METHODS 
 21 
2.6.2. Tagging neuronal ensembles 
Activity-dependent labeling of neurons in CA1 was achieved via injection of 
AAV2/1-cFos-tTA and AAV2/1-PTRE-tight-hM3D(Gq)-mCherry (Zhang, Ferretti et al. 
2015). The cfos promoter (PcFOS) allows the activity-dependent expression of tetracycline-
dependent transactivator (tTA). The presence of doxycycline (DOX), an antibiotic belonging 
to the class of tetracyclines, prevents the binding of tTA to the hM3D(Gq) promoter 
(PTRE-tight). Withdrawal of DOX starts the activity-dependent expression of hM3D(Gq) via 
binding of tTA to PTRE-tight (Fig. 2.3). DOX was delivered with the drinking water in 
lightproof bottles at 2 mg/ml and 5% sucrose from the day of injection on (Zhu, Aller et al. 
2007). For tagging, mice received usual tab water without DOX for two days before they were 
exposed to the novel context B for ten minutes. DOX treatment was continued immediately 
after context B exposure and continued for another four days before contextual fear 
conditioning started. To control for DOX efficiency in preventing the expression of 
hM3D(Gq), a group of mice received DOX, continuously (non-labeled). 
 
Figure 2.3 TetTag-system for activity-dependent labelling within a specified time window. (a) 
Scheme representing the genomes of AAV2/1-cFos-tTA (top) and AAV2/1-PTRE-tight-hM3D(Gq)-mCherry 
(bottom). The transcriptional transactivator (tTA) is expressed in an activity-dependent manner utilizing the c-fos 
promoter (PcFOS). In the absence of doxycycline (DOX) tTA binds to the promoter of hM3D(Gq) (PTRE-tight) and 
starts its expression. Otherwise tTA is bound by DOX and hM3D(Gq) expression is prevented. ITR, inverted 
terminal repeats; WPRE, woodchuck hepatitis virus posttranscriptional regulatory element; pA, polyadenylation 
site. (b) Overview (top) and enlarged (bottom) confocal images showing hM3D(Gq)-mCherry expression in 
absence of DOX in CA1. Scale bar: 500 µm (top), 50 µm (bottom). Modified according to Figure 3 in (Zhang, 
Ferretti et al. 2015). 
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2.6.3. DREADD activation 
Activation of DREADD (designer receptor exclusively activated by designer drugs) was 
achieved via an i.p. injection of 3 µg/g bodyweight clozapine-N-oxide (CNO) 40 minutes 
before memory retrieval (4 mg/ml in 0.9 % NaCl, 1% DMSO). Control mice received an 
injection of a placebo (solvent without CNO). Solutions were prepared freshly at the day of 
experiment. 
2.7. Immunohistochemistry 
2.7.1. Tissue extraction and preparation 
Mice were cardially perfused with ice-cold (∼4 °C) PBS for about five minutes until the liver 
lost its dark red appearance. Brains were carefully removed from the skull without damaging 
the tissue and immediately stored in 4 % paraformaldehyde (PFA). After 24 hours PFA was 
replaced by PBS with 0.01 % of sodium azide (NaN3) for long-term storage at 4 °C, 
preventing bacterial growth. For further immunohistochemistry brains were sliced in PBS 
using a Vibratome.  
2.7.2. Immunohistochemical staining 
Free-floating 100 µm thick brain slices were incubated over night (RT, 300 rpm) in 
0.8 % TritonTM-X100, (Sigma) 4 % normal goat serum (NGS) and 4 % bovine serum 
albumin (BSA), including the first antibody (see section 6.5.3) to obtain permeabilization of 
the tissue and specific antibody binding at the epitopes of interest. After washing with PBS 
(three times for five minutes) the second antibody (1:400, in 3 % BSA) was incubated for 
1.5 hours (RT, 300 rpm). Brain slices were washed with 2% TritonTM-X100 for two minutes 
and three times with PBS for five minutes before either mounting slices on an object plate or 
continuing subsequent chemical staining (Nissl). Chemical stains were incubated (1:200, in 
3 % BSA) for 20 minutes, again including subsequent washing with 2 % TritonTM-X100 and 
PBS. 
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2.8. Image acquisition 
2.8.1. Animal preparation 
For staining Aβ plaques in vivo APP/PS1 mice received 2 µg/g bodyweight methoxy-XO4 
(MeXO4) (0.5 µg/µl MeXO4, 10% DMSO, 45% 1,2-propanediol) (Burgold, Bittner et al. 
2011) i.p. during the handling sessions. Wild-type mice received the same volume of a placebo 
(solvent without MeXO4). To avoid the induction of fosGFP expression by the data 
acquisition procedure itself, mice were anesthetized in their home cage with an i.p. injection of 
ketamine/xylazine, and were carried to the microscope and back under anesthesia. During 
anesthesia eyes were covered with ointment (Bepanthen®) to avoid the eyes from drying. A 
complete imaging session required around 30 minutes. Behavioral experiments, cFC and 
memory test, were conducted 1.5 hours before image acquisition started. During imaging 
under anesthesia mice were attached to a self-made frame that assured proper and reproducible 
fixation of the head below the microscope (Fig. 2.1e). 
2.8.2. Two-photon in vivo images 
FosGFP expression data were acquired with an upright Zeiss Axio Examiner LSM7MP setup 
(Carl Zeiss Microscopy, Jena) equipped with a Coherent Cameleon Ultra II two-photon laser 
(Coherent, Dieburg) and a 16x water immersion objective with a numerical aperture of 0.8 
(Nikon, Tokio). Image acquisition was performed with the software ZEN2010 (Carl Zeiss 
Microscopy, Jena). The eGFP of the fosGFP fusion construct was exited at 920 nm. 
Fluorescence emission was separated by a dichroic mirror (LP555), to detect the green 
(BP 500-550) and red (BP575-610) emitted light with non-descanned detectors. A tile scan 
consisting of 3 x 3 separate z-stacks of 120 µm depth with 3 µm z-spacing, starting at the 
surface of the stratum pyramidale was acquired with a x,y-resolution of 0.496 µm/pix. Tile 
scans were set to a depth of 120 µm to compensate for the curvature of dorsal CA1. For image 
processing and analysis, one to three regions of interest (ROIs) with a depth of 90 µm were cut 
out (see section 2.9.1.). In addition fluorescence of MeXO4-stained Aβ plaque was acquired 
for APP/PS1 mice once per imaging week. Therefore, a 3 x 3 tile scan with a z-spacing of 
5 µm was performed by exciting at 780 nm and detecting blue light emission (BP420-480). 
Repetitive scanning of the same positions over time was achieved by orienting on the basis of 
the vascular pattern under reflected light illumination using a GFP filter set and a metal halide 
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lamp HXP100 (Carl Zeiss Microscopy, Jena). Baseline (BL) and cFC-test period (A-A/B) data 
were acquired for every animal, with a temporal distance of two to three weeks. Structural 
plasticity data of YFP-H mice were acquired at a TrimScopeII setup (La Vision Biotech, 
Bielefeld) equipped with a Coherent Cameleon Ultra II two-photon laser (Coherent, Dieburg) 
and a 16x water immersion objective with a numerical aperture of 0.8 (Nikon, Tokio). Image 
acquisition was performed with ImspectorPro (La Vision Biotech, Bielefeld). YFP-H was 
exited at 920 nm. Fluorescence emission was separated by a dichroic mirror (LP525), to detect 
the yellow (BP 555/55) and blue (BP460/80) emitted light with non-descanned detectors. 
Stacks of 70 µm depth with 1 µm z-spacing, spanning stratum radiatum were acquired with a 
x,y-resolution of 0.087 µm/pixel. Out of every stack two to six dendrites were analyzed as 
previously described (Gu, Kleiber et al. 2014). 
2.8.3. Confocal images 
Confocal images of fixed and immunohistochemically stained brain slices were acquired using 
an inverted LSM700 microscope (Carl Zeiss Microscopy, Jena) equipped with a 20x air 
objective. Alexa Fluor® 488 (Life technologies, Carlsbad) and fosGFP were excited at 488 nm 
and detected in the green channel (BP 490-555). Alexa Fluor® 647 (Life technologies, 
Carlsbad) was excited at 639 nm and detected in the red channel (LP 640). MeXO4 was 
excited at 405 nm and detected in the blue channel (SP 490). The pinhole was set to an airy 
unit of one. Images with a x,y-resolution of 1.250 µm/pixel (FosGFP, see Fig. 3.1e) and 
0.625 µm/pixel (Fos stain, see Fig. 3.1c, Fig. 3.6.2c,d and Fig.3.6.3c-e) were 
acquired. 
2.9. Image processing and analysis 
2.9.1. Two-photon data processing 
Image processing was conducted using the open source software Fiji. For the analysis of 
fosGFP data first, the signal-to-noise ratio of the 8-bit raw data stacks (ROI: 500 µm x 500 
µm x 90 µm) was improved by eliminating most of the auto-fluorescence, which was 
simultaneously present in the green and the red channel. For this purpose, the red channel was 
subtracted from the green channel. The 30 x 3 µm stack spanning CA1 was maximum 
intensity projected (MIP). MIPs of every imaging time-point were aligned in x,y-direction 
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using the plugin TurboReg (Thevenaz, Ruttimann et al. 1998). For measuring the 
fluorescence intensity of fosGFP expressing neurons, circular masks (Ø 7.45 µm) with 
assigned numbers were placed above every nucleus to identify individual neurons throughout 
the experiment. Mean gray values were determined and displayed in arbitrary units (AU). To 
determine background fluorescence (BG), ten circular masks were placed in regions without 
fosGFP expressing nuclei to measure their mean background intensity (BG1, BG2, …, BG10) 
(Fig. 2.4a). A threshold was applied to define a neuron as fosGFP-positive (fosGFP+) 
or -negative (fosGFP-): TH = mean (BG1-10) + 6 * standard deviation (BG1-10). Neurons with 
intensity values above or below the threshold were defined as fosGFP+ (cyan) or fosGFP- 
(black) respectively. Applying the TH resulted in binary images (Fig. 2.4b,c). Density and 
fluorescence intensity measurements for intra- and intergroup comparisons concerning Aβ 
plaque-dependent fosGFP expression were carried out exclusively in the MIP of the first 
imaging time-point (d1), considering exclusively fosGFP+ neurons (see Figure 3.2). 
Fluorescence intensity values of every mouse were normalized (stretched to a range of 0-256) 
to enhance the contrast. Densities of fosGFP expressing neurons are displayed in neurons per 
1000 µm2. FosGFP expression changes within one day were defined as follows: neurons that 
gain, lose or continue fosGFP expression above TH were assigned to categories of ON (green), 
OFF (magenta) and CON (blue) neurons, respectively (see Fig. 2.4d). The percentage of 
ON, OFF and CON neurons per category referring to the sum of all categories 
(ON+OFF+CON) was calculated and displayed over time. Measuring the average time a 
neuron needs to turn ON and OFF, respectively, confirmed the one-day imaging interval to 
be sufficient to resolve fosGFP expression changes (Fig. 2.4e). FosGFP expression pattern 
analyses (see Fig. 3.5, Fig. 3.6.1 and Fig. 6.2) were calculated by considering d2 to d5, 
but neglecting d1. To analyze Aβ plaque deposition, MeXO4-fluorescence containing z-stacks 
were spatially aligned with corresponding fosGFP-fluorescence containing z-stacks. 
Subsequently, MIPs were prepared. Circular masks with a diameter of 100 µm were placed 
around the center of each MeXO4-positive Aβ plaque to define the different proximity 
regions: (< 50 µm), for neurons residing proximal or (> 50 µm), for neurons residing distant 
to MeXO4-positive Aβ plaques. As a control, the same circular masks were randomly applied 
to data of wild-type mice and referred to as randomly placed virtual Aβ plaques. Analyzes in 
Fig. 3.2 to Fig.3.6.1 belong to the same data set. A detailed description of data set 
composition is mentioned elsewhere (see section 6.2.3.). For the analysis of YFP-H data, 
spines on 2 to 6 dendrites residing in stratum  
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Figure 2.4 Definition of fosGFP expressing neurons. (a) Measurement of background fluorescence 
(BG). Representative fosGFP raw data image with manually placed circular masks (red, ∅ 7.45 µm) to measure 
background fluorescence. (b, c) Method to convert 8-bit raw data into binary images. Measurement of fosGFP 
intensity (b, left). Representative fosGFP raw data (left) and corresponding binary image (right). Circular masks 
(white) were manually placed above putatively fosGFP expressing nuclei. Nuclei with fosGFP fluorescence 
intensity above and below threshold (TH) were defined as fosGFP+ and fosGFP-, respectively (c). (d) Scheme 
visualizing the definition of fosGFP expression changes of individual nuclei within one day (Δd1-2). Expression 
changes have been divided into three categories: Nuclei that become fosGFP+ (ON, green), become fosGFP- 
(OFF, red) and nuclei that keep their expression from one to the other day (CON, blue). (e) Representative 
images after threshold application showing the delay of induced fosGFP expression (left, upper panel) and the 
degradation of the signal (left, lower panel). Average time a neuron needed to turn ON and OFF (right); data 
from n=52 fosGFP+ neurons. Scale bar: 40 µm. 
radiatum of CA1 with an average length of 34.9 ± 3.3 µm (wild-type, mean ± standard 
deviation) and 34.2 ± 5.8 µm (APP/PS1, mean ± standard deviation) were counted as shown 
previously (Gu, Kleiber et al. 2014). Events of emerging (gained) or disappearing (lost) spines 
between two imaging time-points were counted and referred to the dendritic length, resulting 
in densities of lost and gained spines, respectively. The density of transient spines is calculated 
by the sum of lost and gained spine density. Spines that remained stable between two imaging 
time-points were referred to as persistent spines, which is depicted as density of persistent 
spines. 
2.9.2. Confocal data processing 
For measuring fosGFP and endogenous Fos expression in confocal images, circular masks 
(Ø 6.88 µm) with assigned numbers were placed above every nucleus to identify individual 
Fos and/or fosGFP expressing neurons. Mean gray values were determined and displayed in 
arbitrary units (AU). To determine background fluorescence (BG), ten circular masks were 
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placed in CA1 surrounding the fosGFP and/or Fos-expressing nuclei to measure their mean 
background intensity (BG1, BG2, …, BG10). A threshold was applied to define a neuron as 
fosGFP-positive (FosGFP+) and/or Fos-positive (Fos+): TH = mean (BG1-10) + 6 * standard 
deviation (BG1-10). The number of fosGFP+ and Fos+ nuclei was counted in single planes of 
multiple slices per mouse (see section 6.2.3.) and displayed as nuclei per 1000 µm2. 
2.9.3. Statistics 
Statistical analysis and preparation of graphs was performed with GraphPad Prism7 
(GraphPad Software Inc., La Jolla, USA). Subjects were assigned to experimental groups 
before data acquisition. Assignment was determined by genotype and by aiming at a balanced 
proportion of sexes in each group. For data collection, blinding was not possible. Data analysis 
was performed blind to the conditions of the experiment via encrypting file names by a third 
person. Mice were excluded if acquired data sets were incomplete. All data were tested for 
normality with the D’Agostino and Pearson normality test (if n>6) or Shapiro-Wilk normality 
test (if n<6). Normally distributed data are displayed with mean ± standard error of the mean 
(SEM), showing single values in light grey. Pattern frequencies and fosGFP expression changes 
are presented by continuous and dashed lines, reporting the mean ± SEM, respectively. Non-
normally distributed data are displayed in box plots that report the median, 25%- and 
75%-quartile, with whiskers depicting minimum and maximum values of the data. All 
statistical tests applied in this study were two-sided and were mentioned in the corresponding 
figure legend. Figures were prepared with Illustrator CS5 Version 15.0.1 and Photoshop CS5 
Version 12.1 (Adobe, San José, USA). 
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3. RESULTS 
3.1. FosGFP is a reliable marker of endogenous Fos 
The expression of immediate early genes (IEGs) is an established marker for neuronal activity 
and was frequently utilized to visualize memory traces (Horn 2004, Reijmers, Perkins et al. 
2007, Rudinskiy, Hawkes et al. 2012, Denny, Kheirbek et al. 2014). We crossbred fosGFP 
and APP/PS1 mice to monitor fosGFP under healthy (wild-type) and AD-like (APP/PS1) 
conditions (Fig. 3.1a). An immunohistochemical staining for GAD67 revealed Fos to be 
preferentially expressed in excitatory rather then in inhibitory neurons in the CA1 region of 
 
Figure 3.1 Immunohistochemical validation of fosGFP. (a) FosGFP and APP/PS1 mice have been 
crossbred to monitor neuronal activity under healthy and AD-like conditions. (b) Scheme of a coronal brain 
section and the analyzed part of the CA1 region (red). (c) Representative confocal images of endogenous Fos 
expression (anti-Fos) and GABAergic interneurons (GAD67) in CA1. (d) Density of Fos+ nuclei, GAD67-
positive (GAD67+) neurons and double positive fractions in immunohistochemically stained slices. Data from 
n=3 wild-type mice. (e) Representative confocal images of endogenous Fos and fosGFP expression in CA1 of 
wild-type and APP/PS1 mice. Aβ plaques were stained by an i.p. injection of methoxy-XO4 (MeXO4). 
(f) Fraction of fosGFP+ nuclei that were simultaneously positive for endogenous Fos protein. Data from n=3 
wild-type and n=3 APP/PS1 mice. Scale bars: 50 µm (c); 40 µm (e). 
the hippocampus (Fig. 3.1b-d). Additionally, fosGFP revealed to be a reliable representative 
of endogenous Fos expression levels as more than 95 % fosGFP-positive (fosGFP+) neurons 
were also positive for the endogenous Fos protein in wild-type and APP/PS1 mice 
(Fig. 3.1e,f). In summary, fosGFP expression proved to be a reliable marker for the study of 
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CA1 neuronal activity under healthy and AD-like conditions. To investigate whether CA1 
neuronal activity dynamics were different in wild-type and APP/PS1 mice, fosGFP expression 
over time was monitored. 
3.2. Presence of amyloid-beta induces neuronal hypoactivity in vivo 
To monitor the expression of the fusion construct fosGFP in vivo, a chronic hippocampal 
window was established in our lab (Gu, Kleiber et al. 2014) (see section 2.3) that allows for 
repetitive scanning of the dorsal hippocampus via two-photon microscopy (Fig. 3.2a-c). Aβ 
 
Figure 3.2 Reduced fosGFP expression in Aβ  plaque vicinity. (a, b) Hippocampus two-photon 
in vivo imaging approach. A stainless-steel cylinder with a glass bottom was implanted above the hippocampus, 
unilaterally (a) to allow repetitive imaging of dorsal CA1 (b). (c) Tile scan (left) and example ROI (right) of 
fosGFP expression (cyan) in dorsal CA1. The dashed cyan-colored line corresponds to the imaged area in (b). 
The white rectangle surrounds the enlarged example ROI (right). (d-f) Density of fosGFP+ nuclei in dependence 
of Aβ plaque vicinity. Binary images of fosGFP+ nuclei in CA1 of wild-type (d, left) and APP/PS1 mice (d, right). 
Density of fosGFP+ nuclei in the whole ROI (e), and near (<50 µm) and far (>50 µm) from MeXO4-positive Aβ 
plaques, or randomly placed virtual plaques (f). (e) p=0.5476, unpaired t-test. (f) p=0.9827 (wild-type near vs. 
APP/PS1 near), p=0.9827 (wild-type far vs. APP/PS1 far), p=9863 (wild-type far vs. APP/PS1 near), p=9827 
(APP/PS1 near vs far), one-way ANOVA with Holm-Sidak’s correction for multiple comparisons. (g-i) FosGFP 
intensity in dependence of Aβ plaque vicinity. Images of fosGFP expressing nuclei in wild-type (g, left) and 
APP/PS1 mice (g, right). Fluorescence intensity distribution in the whole ROI (h), and near and far from 
MeXO4-positive Aβ plaques, or randomly placed virtual plaques (i). (h) p=0.0979 Mann-Whitney test; (i) 
***p=0.0003 (wild-type near vs. APP/PS1 near), p>0.9999 (wild-type far vs. APP/PS1 far), **p=0.0035 (wild-
type far vs. APP/PS1 near), ***p=0.0004 (APP/PS1 near vs. far), Kruskal-Wallis test with Dunn’s correction for 
multiple comparisons. White circles (radius: 50 µm); (d, g) depict the area near to a MeXO4-positive Aβ plaque 
or a virtual plaque (wild-type), respectively. Data from n=8 wild-type mice (2874 neurons) and n=6 APP/PS1 
mice (2092 neurons). Scale bars: 250 (c, left), 100 µm (c, right); 50 µm (d, g). 
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plaques have been shown to influence neuronal firing in the cortex and hippocampus in vitro 
and in vivo (Palop, Chin et al. 2007, Busche, Chen et al. 2012). Arc expression, another IEG, 
was reduced in the vicinity of Aβ plaques and its experience-induced expression regulation was 
altered in the visual cortex in vivo (Rudinskiy, Hawkes et al. 2012). In our mouse model, the 
density of fosGFP expressing neurons was independent of Aβ plaque presence (Fig. 3.2d-f). 
Moreover, the fluorescence intensity distribution of fosGFP expression measured independent 
of Aβ plaque presence was similar in APP/PS1 compared to wild-type mice (Fig. 3.2g,h). 
However, analyzing fosGFP expressing neurons according to their relative distance to 
MeXO4-positive Aβ plaques revealed a significantly decreased expression of fosGFP in the 
direct proximity (<50 µm, near), but not distant (> 50µm, far) to Aβ plaques (Fig. 3.2g,i).  
3.3.  Two major populations among fosGFP expressing neurons 
To analyze learning-induced expression changes of fosGFP, the baseline dynamics were 
monitored first. Therefore, fosGFP fluorescence in the pyramidal cell layer of CA1 was 
scanned daily for a period of five days (Fig. 3.3a). To visualize expression changes, the 
acquired images were transformed into binary images (see section 2.9.1) and color-coded to 
distinguish between neurons that switch on (ON, green), switch off (OFF, magenta) or 
continue their fosGFP expression (CON, blue) from one to the other day (Fig. 3.3b and 
Fig. 2.4d). Comparing the relative fractions of each category revealed the CON fraction to 
be the major subset of neurons comprising ∼60%. In contrast, ON and OFF neurons 
represent just ∼20% each. All categories were of similar size comparing wild-type and 
APP/PS1 mice (Fig. 3.3c). Furthermore, their sizes were consistently over time within both 
genotypes (Fig. 3.3d,e). The population of CON neurons contained a major fraction of 
neurons expressing fosGFP for the whole imaging period of five days. This was confirmed by 
subdividing neurons according to their expression duration: Neurons with constant five-day 
fosGFP expression represented the major fraction (Fig. 3.3f,g). Even three weeks later, 60% 
of this population exhibited five-day long fosGFP expression underscoring their long-term 
continuous activity (Fig. 3.3h). The second most frequent fraction consisted of neurons 
expressing fosGFP just once in five days, representing a variably active neuronal population of 
the CA1 network. The remaining population consisted of neurons with fosGFP expression 
durations of two, three and four days, with lower frequencies compared to afore mentioned 
populations. Similar frequencies were found in wild-type and APP/PS1 mice (Fig. 3.3g). In 
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summary, the analysis of fosGFP expression kinetics during baseline within the same CA1 
pyramidal neurons revealed two major populations: a continuously active (CON) and a 
variably active one (ON, OFF). 
 
Figure 3.3 FosGFP baseline dynamics revealed two distinct neuronal populations. (a) 
Experimental paradigm to monitor daily fosGFP expression under baseline (BL) conditions, with mice residing in 
their home cage (HC). (b) FosGFP expression changes are visualized in green (ON, switch on), magenta (OFF, 
switch off) and blue (CON, continue expression). Categories define expression changes between two days, e.g.: 
Δd1-2, expression changes between d1 und d2. (c) Average fraction of each category within one week in wild-
type and APP/PS1 mice. Inter-group comparisons: ON, p=0.8685; OFF, p=0.9040; CON, p=0.8685; two-way 
ANOVA with Holm-Sidak’s correction for multiple comparisons. (d, e) Representative example images (left) 
and corresponding graphs (right) depicting fosGFP expression changes within five days in wild-type (d) and 
APP/PS1 mice (e). (f) Example image showing fosGFP+ nuclei and their fate regarding the expression duration 
(color-coded). (g) Fraction of neurons with different expression durations, from one to five days. Inter-group 
comparisons: 1, p=0.8966; 2, p=0.9534; 3, p=0.9630; 4, p=0.9630; 5, p=0.9534; two-way ANOVA with Holm-
Sidak’s correction for multiple comparisons. (h) Three week survival of neurons with a expression duration of 
five days (d1 to d5) in wild-type and APP/PS1 mice, respectively; p=0.214, unpaired t-test. Data from n=8 wild-
type (4134 neurons) and n=6 APP/PS1 mice (2993 neurons). Scale bar: 50 µm. 
3.4. Intact CA1 activity of APP/PS1 mice during learning & memory 
It was hypothesized that impaired learning and memory on the behavior level is reflected by 
altered CA1 network activity in APP/PS1 mice. Therefore learning-induced expression 
changes of fosGFP in CA1 pyramidal neurons were examined (Fig. 3.4a). APP/PS1 mice  
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Figure 3.4 CA1 network activity revealed to be intact in APP/PS1 mice. (a) Experimental 
timeline to access fosGFP expression during learning and memory. Images were acquired every day for a period of 
five days. On day three, mice underwent contextual fear conditioning (cFC). On day five mice were either tested 
(test) in the conditioned context A (white-colored box) or in a novel context B (salmon-colored box). (b) 
Memory test performance measured by freezing behavior of wild-type and APP/PS1 mice in the conditioned 
context A, two days after conditioning. Freezing of wild-type mice conditioned in context A, but exposed to a 
novel context B two days after conditioning as a control for freezing specificity. Data from n=16 wild-type A-A, 
n=14 APP/PS1 A-A and n=10 wild-type A-B mice; *p=0.0322 (wild-type A-A vs. APP/PS1 A-A), **p=0.0014 
(APP/PS1 A-A vs. wild-type A-B), ****p<0.0001 (wild-type A-A vs. wild-type A-B); one-way ANOVA with 
Holm-Sidak’s correction for multiple comparisons. (c) Freezing behavior during context A exposure, before the 
first shock was delivered (pre-shock). (d-f) Representative images of fosGFP expression changes in wild-type (d) 
and APP/PS1 mice (e) conditioned and tested in context A (A-A) and of wild-type mice conditioned in context 
A, but tested in context B (A-B) (f). (g-i) Inter-group comparisons of fold changes of ON (g), OFF (h) and 
CON (i) fractions during the cFC-test period. Average values from n=8 wild-type A-A mice (4775 neurons), n=6 
APP/PS1 A-A mice (3776 neurons) and n=6 wild-type A-B mice (5099 neurons); *p=0.0264 (Δd4-5, wild-type 
A-A vs. wild-type A-B), all other comparisons resulted in p-values > 0.05, two-way ANOVA with Holm-Sidak’s 
correction for multiple comparisons. Scale bar: 25 µm. 
have a long-term memory retrieval deficit (Kilgore, Miller et al. 2010, Roy, Arons et al. 2016). 
The contextual memory retrieval deficit was successfully confirmed in this work by exposing 
mice to the conditioned context A two days after conditioning. This revealed a significantly 
decreased freezing rate of APP/PS1 mice, compared to wild-type mice. A control group was 
conditioned in context A, but exposed to a novel context B, showing that the freezing behavior 
was specific to the conditioned context (Fig. 3.4b). General differences in freezing behavior 
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between genotypes can be excluded by comparing the baseline freezing rates during 
exploration of context A (pre-shock) (Fig. 3.4c). To identify whether the decreased memory 
test performance of APP/PS1 mice was due to impaired memory acquisition and/or retrieval 
on the cellular level, contextual fear conditioning (cFC) was combined with two-photon in 
vivo imaging, adapted to the previously applied experimental timeline (see Fig. 3.3a). To 
obtain stimulus-evoked fosGFP expression, behavioral experiments were carried out 1.5 hours 
before the imaging started to compensate for the delay of GFP expression (Fig. 2.4e). 
Indeed contextual fear conditioning evoked a strong increase of ON neurons causing an 
overall rise of fosGFP-positive (fosGFP+) nuclei (Fig. 3.4d-g). This effect was similar in 
wild-type and APP/PS1 mice, indicating intact memory acquisition on the level of neuronal 
activity. The following day was characterized by an increased OFF fraction, reducing the total 
number of fosGFP+ nuclei back to baseline values (Fig. 3.4d-f,h). Contextual memory 
retrieval induced just a slight gain of ON neurons in wild-type mice that successfully retrieved 
the memory. The exposure of wild-type mice to a novel context B, two days after conditioning 
in context A induced a gain of ON neurons, similar to the gain after fear conditioning in 
context A (Fig. 3.4g). The fraction of CON neurons did not change after experience 
(Fig. 3.4i). Interestingly, exposing APP/PS1 mice to the conditioned context A, two days 
after conditioning led to a rise of the ON fraction, similar to wild-type mice exposed to the 
conditioning context, indicating intact memory retrieval on the level of integrated neuronal 
activity (Fig. 3.4g). Summarized, the CA1 network of APP/PS1 mice exhibited fosGFP 
expression dynamics during learning and memory similar to wild-type mice. To analyze the 
existence of any hidden difference between CA1 neuronal activity of wild-type and APP/PS1 
mice, the activity of every individual neuron was examined. 
3.5. Reactivated neuronal ensembles occur independent of memory  
It is known that neurons involved in memory encoding are in part reactivated during memory 
retrieval. As the data above showed (see Fig. 3.4g), exposure of wild-type mice to the 
conditioned context A two days after learning induced an increase of ON neurons, although 
smaller compared to the gain after cFC (see also Fig. 6.1). To clarify whether those 
neurons were active during both events, encoding and retrieval, the fraction of reactivated 
neurons (standard reactivation) was calculated (Fig. 3.5a-c). This resulted in a population of  
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Figure 3.5 Reactivated ensemble emerged independent of memory retrieval. (a-e) Reactivation 
analysis. Experimental timeline (a) and definitions of standard (b) and precise reactivation (d) are visualized. 
Corresponding box plots showing reactivated fractions in all experimental groups for the standard (c) and precise 
(e) definition of reactivation. Average values from n=8 wild-type A-A mice (4775 neurons), n=6 APP/PS1 A-A 
mice (3776 neurons) and n=6 wild-type A-B mice (5099 neurons); p-values for intra-group comparisons > 0.05 
(n.s.), *p=0.0341 (wild-type A-A), *p=0.0127 (APP/PS1 A-A), *p=0.0368 (wild-type A-B), two-way ANOVA 
with correction for multiple comparisons using the two-stage linear step-up procedure of Benjamini, Krieger and 
Yekutieli. (f) Scheme for activity pattern analysis. During the BL, A-A and A-B periods four imaging days 
surrounding day three and five, respectively, were considered for analysis. Taking four different time-points and 
two possible activity states, i.e. fosGFP+ and fosGFP-, individual neurons can show 24-1 different activity patterns 
(randomly named from A to O), excluding the neurons without activity. (g) Relative frequency of every activity 
pattern in wild-type and APP/PS1 mice during the cFC-test period A-A, and in wild-type mice during A-B. 
70%, but surprisingly, for all experimental groups. Furthermore, standard reactivation during 
the cFC-test period (A-A/B) equals randomly reactivated fractions, as revealed by baseline (BL) 
data (Fig. 3.5c). As the standard two time-point approach was biased by the subset of 
neurons being continuously active during the experimental timeline, reactivation was defined 
more precisely. For this, just neurons fosGFP+ during cFC and test, and fosGFP- elsewhere, 
were considered (Fig. 3.5a,d,e). This led to a reactivated fraction of around 20%, but again, 
the same for all experimental groups (inter-group comparison). However, this subset of 
neurons was increased compared to BL (intra-group comparison) and led to a specifically 
reactivated fraction of about 10%, subtracting randomly reactivated neurons (Fig. 3.5e). To 
consider other patterns of activity that may give rise to a neuronal correlate of the contextual 
memory and may explain memory impairment in APP/PS1 mice, the relative frequencies of 
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every possible activity pattern was calculated. Giving the possibility of two different states, 
namely fosGFP+ and fosGFP-, and a consideration of four time-points, led to a total number 
of 15 different sequences of fosGFP+ and fosGFP- states, i.e. possible activity pattern 
(Fig. 3.5f). By comparing the relative frequencies of all patterns during the cFC-test period 
(A-A/B) between the experimental groups confirmed the equal rise of the precisely reactivated 
neuronal subset (pattern C) (Fig. 3.5f,g). Interestingly, the comparison also uncovered a 
pattern that is clearly more prevalent in APP/PS1 mice, compared to wild-type mice 
(pattern F) (Fig. 3.5g). This pattern F was also found elevated in wild-type mice tested in 
the novel context B. The relevance of this activity pattern, comprising neurons that are 
activated exclusively after memory retrieval, needs to be examined. Therefore, the aim was to 
further dissect the CA1 network activity during retrieval. 
3.6. Impurity of the memory trace impairs retrieval performance 
In the previous section it was shown that reactivation of a potential memory trace during 
memory test was intact in APP/PS1 mice. The following analysis addresses whether additional 
neuronal ensembles (e.g. pattern F) may present a causal link to the behavioral deficit on the 
cellular level. Therefore, the composition of the retrieval network (RN) was dissected, i.e. the 
entity of neurons fosGFP+ during retrieval. Each neuron of the RN can have one of eight 
possible activity history patterns (Fig. 3.6.1a), consisting of the previously described activity 
patterns including just those being fosGFP+ on day five (see Fig. 3.5f). To identify learning 
and memory related patterns, the change in frequency of every activity history pattern, from 
the baseline (BL) to the cFC-test period (A-A/B), was calculated (Fig. 3.6.1b). Clearly, two 
of the eight possible activity history pattern stood out: REAH pattern (neurons with 
reactivation history, green) that is elevated in all experimental groups (Fig. 3.6.1a-c) and 
RONLY pattern (neurons only active during retrieval, red), that is elevated in APP/PS1 mice 
exposed to the conditioned context A and in wild-type mice exposed to a novel context B 
(Fig. 3.6.1a,b,d). To visualize the overall RN change between experimental groups, a 
network similarity map was designed. Here, activity history pattern were sorted according to 
their relative frequency change from the BL to the cFC-test period in descending order. Each 
corresponding pattern was connected by a line. A high number of intersections indicate a high 
dissimilarity, whereas a low number of intersections indicate a high similarity of the neuronal  
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Figure 3.6.1 Superimposition as determinant of retrieval performance. (a) Scheme presenting the 
activity history analysis of neurons composing the retrieval network (RN). Every possible activity history is 
presented by a subset of previously introduced pattern (Fig. 3.5f). (b) Change of frequency of every RN activity 
history pattern from BL to A-A/B in percent. (c) Frequency change for neurons showing a reactivation history 
(REAH) from BL to A-A/B in percent. (d) Frequency change from BL to A-A/B in percent, for neurons being 
fosGFP+ exclusively on day 5 (RONLY). (e) Network similarity map. RN activity history patterns of every 
experimental group are ordered by their frequency change, from top to bottom in a descending order. Lines 
connect corresponding patterns. The fewer intersections occur the more similar are the compared RNs. Data 
from n=8 wild-type A-A, n=6 APP/PS1 A-A and n=6 wild-type A-B mice; (c) p=0.2926 (wild-type A-A vs. 
APP/PS1 A-A), p=0.9441 (wild-type A-A vs. wild-type A-B), p=0.2926 (APP/PS1 A-A vs. wild-type A-B); (d) 
*p=0.0426 (wild-type A-A vs. APP/PS1 A-A), *p=0.0109 (wild-type A-A vs. wild-type A-B), p=0.4450 (APP/PS1 
A-A vs. wild-type A-B); one-way ANOVA with Holm-Sidak’s correction for multiple comparisons. (f) Model 
visualizing the superimposition of the memory trace. 
network state (Fig. 3.6.1e). The network similarity map revealed a clear RN similarity 
between APP/PS1 mice exposed to the conditioned context A and wild-type mice exposed to a 
novel context B, especially for patterns with the highest frequency change. Summarized, the 
data revealed an intact potential engram in the RN, represented by REAH neurons (green), in 
all experimental groups. Additional activity consisting of RONLY neurons (red) was present in 
groups showing reduced recall performance. This suggests impaired retrieval performance 
through superimposition of the memory trace by impurity of the RN (Fig. 3.6.1f). To test 
this hypothesis, superimposition was induced artificially. Therefore, Vglut2-ires-cre mice were 
injected bilaterally with an AAV containing the genetic information for an activating 
DREADD (designer receptor exclusively activated by designer drug, hM3D(Gq)), flanked by  
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Figure 3.6.2 Artificial superimposition in CA1 impaired retrieval performance. (a, b) Schematic 
showing hM3D(Gq)-mediated activation of CA1 neurons during memory retrieval to artificially superimpose the 
memory trace. An AAV carrying an activating DREADD (designer receptor exclusively activated by designer 
drugs) flanked by loxP sites was injected into CA1 of Vglut2-ires-cre mice, bilaterally. (b) Experimental timeline 
for assessing memory retrieval performance during artificial memory trace superimposition. Two weeks after 
injections, mice underwent cFC and memory test. Here, mice received CNO or placebo, 40 minutes prior to test. 
90 minutes after memory test, mice were sacrificed for postmortem immunohistochemical analysis of brain tissue 
(IHC). (c, d) Overview (left) and zoom (right) of exemplary confocal images of coronal brain sections showing 
CA1 targeted expression of hM3D(Gq)-mCherry and Fos in (c) placebo- and (d) CNO-treated mice. (e) Density 
of Fos expressing neurons in placebo- and CNO-treated mice; ****p<0.0001, unpaired t-test. (f) Freezing 
behavior of placebo- and CNO-treated mice; *p=0.0316, unpaired t-test. Data from n=5 CNO-treated and n=4 
saline-treated mice. Scale bars: (c) 500 µm (left), 50 µm (right). 
loxP sites to target its expression to excitatory glutamatergic neurons in hippocampal CA1 
(Fig. 3.6.2a). After a recovery period mice underwent contextual fear conditioning (cFC).  
Memory was retrieved two days later, but with a previous activation of hM3D(Gq)-positive 
cells via an injection of clozapine-N-oxide (CNO) or placebo (just solvent) 40 minutes before 
memory test, respectively (Fig. 3.6.2b). CNO successfully increased neuronal activity in 
CA1 as revealed by an elevated number of Fos+ nuclei, compared to placebo-injected control 
mice (Fig. 3.6.2c-e). Mice with increased neuronal activity in CA1 showed significantly 
reduced freezing behavior during memory test than placebo-injected control mice (Fig. 
3.6.2f). This result supports the hypothesis established above: increased non memory-specific 
neuronal activity in CA1 during memory retrieval, superimposes the memory trace and hence, 
leads to reduced retrieval performance. To test whether activation of false context information 
alone is sufficient to impair memory, we utilized an activity-dependent and doxycycline 
(DOX)-controllable AAV expression system (TetTag-System) (Fig. 2.3)  
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Figure 3.6.3 Superimposition by false context information in CA1 impaired retrieval 
performance. (a, b) Schematic showing the labeling and activation of CA1 neurons coding for false context 
information during memory retrieval to artificially superimpose the memory trace. A combination of two AAVs 
(TetTag-system) providing activity-dependent and doxycycline (DOX)-controlled expression of the activating 
DREADD hM3D(Gq) was injected into CA1, bilaterally. (b) Experimental timeline for tagging and activating 
neurons coding for a novel context B during memory retrieval of the conditioned context A. Mice were kept on 
DOX from the day of injections on (grey horizontal bar). For labeling neurons coding for a false context, mice 
were exposed to context B after two days without DOX. Control mice were kept on DOX during context B 
exposure (non-labeled). On d7 and d9, mice underwent cFC and memory test, respectively. Here, mice received 
CNO or placebo, 40 minutes prior to test. 90 minutes after memory test, mice were sacrificed for postmortem 
immunohistochemical analysis of brain tissue (IHC). (c-e) Overview (left) and zoom (right) of exemplary 
confocal images of coronal brain sections showing CA1 targeted expression of hM3D(Gq)-mCherry and Fos in 
placebo- (c) and CNO-treated (d) and non-labeled mice (e). (f) Density of Fos expressing neurons in placebo-
treated, CNO-treated, and non-labeled mice. Data from n=7 placebo-treated, n=8 CNO-treated and n=5 non-
labeled mice; **p=0.0018 (placebo- vs. CNO-treated), ***p=0.0005 (CNO-treated vs. non-labeled), p=0.2643 
(placebo-treated vs. non-labeled); ordinary one-way ANOVA with Holm-Sidak’s correction for multiple 
comparisons. (g) Freezing behavior of CNO- and placebo-treated mice. Data from n=10 placebo- and n=10 
CNO-treated mice; *p=0.0379, unpaired t-test. Scale bars: (c) 500 µm (left), 50 µm (right). 
(Zhang, Ferretti et al. 2015). The first AAV provides the activity-dependent expression of a 
tetracyclin transactivator (tTA). In absence of doxycycline (DOX), tTA binds to a promoter 
region present on the second virus genome (PTRE-tight), driving hM3D(Gq)-mCherry 
expression. The presence of DOX prevents tTA to bind on PTRE-tight and thus, allows a 
temporally restricted expression of hM3D(Gq). Both AAVs were injected into CA1, bilaterally 
and DOX was given from that time on (Fig. 3.6.3a,b). For labeling neurons that encode 
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contextual information of a novel environment (context B), mice were deprived of DOX for 
two days and exposed to context B for ten minutes. To control for efficient expression 
prevention, a group of mice received DOX continuously (non-labeled). After four days mice 
were fear conditioned in context A. Memory was retrieved two days after cFC with a previous 
injection of CNO or placebo, respectively. CNO successfully induced the activation of the 
tagged neurons, as shown by an elevated number of Fos+ nuclei compared to placebo-treated 
and non-labeled control mice (Fig. 3.6.3c-f). As expected, the change of activated neurons 
appeared much smaller, compared to the previous approach (Fig. 3.6.2e). Nevertheless, 
activation of tagged neurons during memory retrieval reduced memory recall performance, 
compared to placebo-treated control mice (Fig. 3.6.3g). Hence, activation of false context 
information in CA1 alone is sufficient to impair memory retrieval in the conditioned context. 
In the context of AD, an imbalance of excitation and inhibition was hypothesized to represent 
a possible cause of pathologies and thus, the cause of impaired memory (Palop, Chin et al. 
2006). Whether a malfunction of inhibitory activity relates to our observed superimposition of 
the memory trace in APP/PS1 mice will be further analyzed. 
3.7. PV+ interneurons are crucial for CA1 activity modulation 
Inhibitory interneurons are crucial for the complex interplay of neuronal circuits and have 
been shown to fulfill indispensable roles during learning and memory processes (Donato, 
Rompani et al. 2013). Especially in Alzheimer’s disease, the fine balance of excitatory and 
inhibitory processes was shown to be disturbed (Palop, Chin et al. 2006). Therefore, it was 
hypothesized that the superimposition of the memory trace in APP/PS1 mice might originate 
indirectly from hypoactivity of inhibitory interneurons. To test this hypothesis and reveal the 
role of interneurons in contextual learning and memory processes within the hippocampus, 
interneuronal activity was suppressed artificially during learning and memory, respectively. 
APP/PS1 mice were crossbred to PV-Cre (parvalbumin-cre) mice to obtain PV-Cre transgenic 
mice with (APP/PS1) and without (wild-type) the APP/PS1 transgene. To manipulate 
interneurons’ activity, the silencing opsin halorhodopsin (eNpHR) was delivered to 
parvalbumin-expressing (PV+) interneurons in a cre-dependent manner using AAV injections 
targeted to CA1 of wild-type and APP/PS1 mice, bilaterally (Fig. 3.7a). Two-ferrule 
cannulas were implanted above CA1 without damaging the pyramidal cell layer to repetitively  
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Figure 3.7 PV + interneurons were crucial for memory encoding and retrieval. (a-d) Experimental 
approach to selectively inhibit PV-expressing (PV+) interneurons in CA1 during learning and memory. 
(a) Expression of an inhibiting opsin (NpHR) flanked by loxP sites was targeted to PV+ interneurons CA1 
interneurons via bilateral AAV injection into wild-type and APP/PS1 mice. Control mice of both genotypes 
received a red fluorophore, flanked by loxP sites (sham). (b) Scheme (left) and exemplary picture (right) of an 
implanted two-ferrule cannula that can be reversibly coupled to a light source. (c) Exemplary confocal image of a 
coronal section showing tdTomato expression targeted to PV+ interneurons and the site of implantation. 
(d) Experimental timeline to manipulate interneuron activity during learning and memory. OFT, open field test; 
ON (yellow bar), light stimulation; OFF (white bar), no light stimulation. (e) Travelled distances of all 
experimental groups in an OFT during light stimulation. (f) Freezing behavior of wild-type and APP/PS1 mice, 
NpHR- and sham- injected, during memory test I (f); *p=0.0254 (wild-type sham vs. wild-type NpHR), 
*p=0.0248 (wild-type sham vs. APP/PS1 sham), all other comparisons resulted in p-values > 0.05 (n.s.); one-way 
ANOVA. (g) Freezing behavior of wild-type NpHR-injected mice during test I and III, and sham-injected mice 
during test I in absence of light stimulation (OFF); *p=0.0113, **p=0.0015, p=0.6948; one-way ANOVA. 
(h) Memory retrieval performance of wild-type NpHR-injected mice with (test III, ON) and without (test II, 
OFF) PV+ interneuron inhibition; *p=0.0403, paired t-test. Data from n=7 wild-type sham, n=11 wild-type 
NpHR, n=5 APP/PS1 sham and n=7 APP/PS1 NpHR mice. Scale bar: 1 mm (c). 
stimulate eNpHR-containing PV+ interneurons (Fig. 3.7b). Control animals underwent the 
same procedures, with the eNpHR being substituted by a red fluorophore (tdTomato) without 
any biological effect (sham) (Fig. 3.7a,c). The experimental timeline was chosen to 
manipulate the activity of PV+ interneurons during different stages of the behavioral paradigm 
to elaborate their necessity during learning and memory (Fig. 3.7d). An open field test 
(OFT) during light stimulation revealed equal exploratory behavior between genotypes, 
excluding a bias due to motor differences or fiber-attached behavior (Fig. 3.7e). Inhibiting 
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PV+ interneurons during memory acquisition resulted in reduced memory retrieval 
performance in wild-type mice compared to sham mice (Fig. 3.7f). Inhibition of PV+ 
interneurons during learning in APP/PS1 mice increased their memory retrieval performance, 
similar to the performance of wild-type sham mice. But an intra-group comparison did not 
reach significance (Fig. 3.7f). Interestingly, the performance of wild-type NpHR mice 
dropped to the level of APP/PS1 sham mice. Re-conditioning of wild-type mice that 
previously received inhibition of PV+ interneurons during learning revealed a reversible effect 
(Fig. 3.7g). Inhibition of PV+ interneurons during memory retrieval also reduced memory 
test performance of wild-type mice (Fig. 3.7h). This was shown by exposing the same group 
of wild-type mice again to the conditioned context, with (test III) and without (test II) 
inhibition of PV+ interneurons during the test. In APP/PS1 mice, PV+ interneuron inhibition 
during retrieval did not influence performance (data not shown). Summarized, the data 
revealed a crucial role of PV+ interneurons during learning and memory processes and suggest 
a causal effect of hypoactive PV+ interneurons for the memory retrieval impairment of 
APP/PS1 mice. 
3.8. Altered synaptic correlates of learning under AD-like conditions 
Dendritic spines represent the postsynapse of excitatory neurons and have been shown to 
exhibit structural plasticity. As a correlate of synapses, spines change their morphology and 
appearance upon experience in the cortex (Hubener and Bonhoeffer 2010). Structural 
plasticity of dendritic spines in stratum radiatum of the hippocampal area CA1 was recently 
demonstrated in vivo (Gu, Kleiber et al. 2014, Attardo, Fitzgerald et al. 2015). However, 
conflicting data exist regarding the turnover of dendritic spines in the hippocampus. In the 
present study, YFP-H transgenic mice were crossbred to APP/PS1 mice resulting in YFP 
expressing mice, with (APP/PS1) and without disease background (wild-type) (Fig. 3.8.1a). 
The experimental timeline was designed to measure spine density and turnover during baseline 
(BL) as well as throughout learning and memory (LM) (Fig. 3.8.1b). As shown before 
(see Fig. 3.4b) APP/PS1 mice freeze less during exposure to context A two days after 
(Fig. 3.8.1c), but not before conditioning (Fig. 3.8.1d). Image stacks spanning the 
stratum radiatum (SR) of CA1 were acquired repetitively from the same region of interest 
(Fig. 3.8.1e,f). Spine density was constant over time in wild-type and APP/PS1 mice, but 
significantly reduced in APP/PS1 mice (Fig. 3.8.1g,h). Interestingly, the decreased spine  
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Figure 3.8.1 Altered structural plasticity in CA1 of APP/PS1 mice. (a) YFP-H and APP/PS1 
transgenic mice were crossbred to obtain YFP-H transgenic mice with (APP/PS1) or without the APP/PS1 
transgene (wild-type). (b) Experimental timeline to monitor the fate of dendritic spines during baseline (BL) and 
learning and memory (LM). (c, d) Freezing behavior of wild-type and APP/PS1 mice before conditioning 
(d, pre-shock) and during memory test, two days after conditioning (c). Data from n=10 wild-type and n=8 
APP/PS1 mice; *p=0.0152 (c), p=0.0704 (d); unpaired t-test. (e) Scheme showing a pyramidal neuron of the 
hippocampal area CA1. Spine data of CA1 pyramidal neurons were acquired in the stratum radiatum (SR). 
SO, stratum orins; SP, stratum pyramidale; S-LM, stratum lacunosum moleculare. (f, g) Overview images (f) and 
corresponding excerpts of enlarged dentrites (g) of YFP-H expressing neurons in wild-type and APP/PS1 mice, 
respectively. (h) Density of dendritic spines throughout the experimental timeline; **p=0.0048 (d1, BL), 
**p=0.0032 (d3, BL), **p=0.0086 (d5, BL), **p=0.0036 (d1, LM), **p=0.0066 (d3, LM), *p= 0.0103 (d5, LM); 
inter-group comparisons conducted with two-way ANOVA. (i) Densities of permanent spines during BL and 
LM; **p=0.0035 (Δd1-3, BL), **p=0.0049 (Δd3-5, BL), **p=0.0083 (Δd1-3, LM), **p=0.0092 (Δd3-5, LM), 
inter-group comparisons conducted with two-way ANOVA. (j) Densities of transient spines during BL and LM; 
p=0.9683 (Δd1-3, BL), p=0.8658 (Δd3-5, BL), *p=0.0366 (Δd1-3, LM), p=0.4334 (Δd3-5, LM). 
Δd1-3, interval between day one and day three; Δd3-5, interval between day three and day five. Data from n=8 
wild-type and n=4 APP/PS1 mice. Scale bars: 20 µm (f), 2 µm (g). 
density mainly originates from a reduction in permanent spines, with a lifetime of two or more 
days (Fig. 3.8.1i). In contrast, transient spines with a lifetime of less than two days are 
comparable between genotypes during BL (Fig. 3.8.1i). However, after cFC the density of 
transient spines significantly increased in wild-type mice, a change that was absent in APP/PS1 
mice (Fig. 3.8.1i). In contrast, the density of permanent spines remained constant during 
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cFC and test (Fig. 3.8.1h). Analyzing learning-induced density changes of transient spines 
revealed that the increase of transient spines was related to significantly more lost spines. The 
density of gained spines remained constant (Fig. 3.8.2a-c). Memory retrieval did not 
induce any profound changes in spine density (Fig. 3.8.2d-f). Summarized, learning 
induced an increased density of lost spines on the apical dendrites of CA1 pyramidal neurons, 
whereas memory retrieval did not influence the structural plasticity of spines in stratum 
radiatum.  
       
Figure 3.8.2 Learning-induced spine loss was absent in APP/PS1 mice. (a) Representative two-
photon images of dendrites in SR of wild-type and APP/PS1 mice before (d1) and after cFC (d3). 
(b,c) Densities of lost (b) and gained (c) spines in wild-type and APP/PS1 mice, respectively. The densities of 
the first interval (Δd1-3) during BL and LM (grey shaded) are compared; (b) *p=0.0415 (Δd1-3 wild-type, BL vs. 
LM), p=0.7301 (Δd1-3 APP/PS1, BL vs. LM); (c) all comparisons p>0.05 (n.s.), two-way ANOVA. 
(d) Representative two-photon images of dendrites in CA1 SR of wild-type and APP/PS1 mice during test. 
(e  f) Densities of lost (e) and gained (f) spines in wild-type and APP/PS1 mice, respectively. The densities of the 
second interval (Δd3-5) during BL and LM (grey shaded) are compared. All comparisons p>0.05 (n.s.), two-way 
ANOVA. Data from n=8 wild-type and n=4 APP/PS1 mice. Scale bar: 2µm (a,d).  
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4. DISCUSSION 
This study revealed the existence and composition of a cellular engram representing a 
contextual memory in the CA1 region of the hippocampus of mice. The engram of a recent 
memory was shown to be rather small, including just 10% of neurons that have been activated 
during learning. Moreover, the engram itself was intact in a mouse model of AD. Instead, 
aberrant CA1 network activity resembling a novelty signal was present during memory 
retrieval, potentially superimposing the engram and hence, causing impaired memory retrieval. 
Mimicking superimposition in CA1 on different scales indeed induced retrieval impairment in 
wild-type mice. Additionally, the importance of PV+ interneurons, a subset of inhibitory 
neurons, was identified for learning and memory. Pathology in APP/PS1 mice was shown to 
have no influence on baseline CA1 network activity, measured by fosGFP expression changes. 
However, fosGFP intensity was decreased in the direct vicinity of Aβ plaques. On the 
structural level, APP/PS1 mice exhibit a decreased density of spines at apical dendrites in 
stratum radiatum of CA1 pyramidal neurons. Furthermore, learning did not induce the loss of 
dendritic spines observed in wild-type mice, revealing an experience-dependent network 
malfunction on the structural level. In summary, the present study provides a novel 
mechanism for memory impairment in a mouse model of AD: Superimposition of the 
memory trace. Besides, the importance of inhibitory modulation in the hippocampus during 
learning and memory was stressed. Both, observed impairments in learning-dependent shaping 
of dendritic spines and an impaired inhibition provide potential mechanisms underlying the 
superimposition of the memory trace in CA1 during retrieval in APP/PS1 mice.  
4.1. Functional and methodological aspects of fosGFP  
The mRNA and protein products of immediate early genes are established markers for 
neurons that have been recently activated (Horn 2004). They represent one of the fastest 
intracellular expression changes upon neuronal activity and serve as activity footprints. A 
recent study already examined Arc expression in the extrastriate visual cortex repetitively upon 
visual stimulation (Rudinskiy, Hawkes et al. 2012). However, until now existing methods 
failed to longitudinally monitor IEG expression dynamics in the hippocampus in vivo. Here, 
we applied a chronic hippocampal window to repetitively examine the same neuronal 
populations with two-photon microscopy. This allowed to monitor neuronal activity for an 
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infinite number of points in time, thus enabling the observation of the baseline and 
experience-induced dynamics of fosGFP expression within the same CA1 pyramidal neurons. 
We demonstrated the reliability of fosGFP as a marker for endogenous Fos (Fig. 3.1). 
FosGFP visualizes neurons that had been recently activated and provides an integral of 
multiple calcium events. Sophisticated methods exist to visualize almost real-time activity of 
neurons via imaging of calcium dynamics. However, this involves either head fixation or 
connection to a mobile microscope, approaches that imply extensive habituation of the 
animal. The delay of fosGFP expression allows the separation of the behavioral experiment 
and the imaging session, reducing behavioral bias by the imaging procedure or vice versa. After 
cFC, fosGFP required around 1.5 hours to be expressed in CA1 pyramidal neurons in vivo 
(Fig. 2.4e). This is in line with a study examining fosGFP expression in the paraventricular 
nucleus upon a dehydration stimulus and subsequent water deprivation in vivo (Barth, Gerkin 
et al. 2004). Fluorescence signal decline was detectable on average six hours after onset of 
fosGFP expression (Fig. 2.4e). The chosen imaging time intervals were adapted to the 
fosGFP expression dynamics and were well suited to monitor daily fosGFP expression changes 
within the neuronal population of CA1 neurons.  
4.2. Influence of amyloid-β pathology on fosGFP expression 
Neurons residing close (< 50 µm) to MeXO4-positiv amyloid-β (Aβ) plaques showed a 
decreased fosGFP fluorescence intensity compared to neurons distant (> 50 µm) to Aβ 
plaques, which hints at neuronal hypoactivity. To exclude random occurrence of low-
fluorescent spots, the intensity distribution of fosGFP expressing neurons was examined also in 
wild-type mice in dependence to randomly placed virtual plaques. Here, no intensity 
distribution difference was observed. The finding of hypoactivity corresponds to a study 
performing calcium imaging in the hippocampus of AD mice. They reported an increased 
fraction of neurons with low activity < 60 µm around Aβ plaques (Busche, Chen et al. 2012). 
The definition of the silent population of neurons comprised those having 0 - 0.2 calcium 
transients per minute. The observed population of neurons with reduced fosGFP expression 
might represent a population with a low firing frequency caused by soluble Aβ. Possible 
mechanisms leading to neuronal hypoactivity are potentially driven by soluble Aβ oligomers, 
that were reported to form a high-concentration halo around Aβ plaques, composing a toxic 
microenvironment (Koffie, Meyer-Luehmann et al. 2009). Aβ plaque cores itself have been 
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shown to be largely inactive (Shankar, Li et al. 2008). Oligomeric Aβ was shown to induce 
internalization of NMDA receptors (NMDARs), one of the main glutamate ionotropic 
receptors (Snyder, Nong et al. 2005). This can cause reduced glutamatergic transmission 
(Freir, Holscher et al. 2001), causing synaptic failure, which in turn can lower the input of an 
affected neuron, decrease its firing and consequentially cause decreased activation of the c-fos 
promoter, explaining reduced fosGFP fluorescent intensity. The internalization of NMDARs 
can also have a direct effect on Fos expression, since NMDAR-dependent Ca2+ influx and 
subsequent downstream signaling mainly drive c-fos promoter activation. Thus, a reduction of 
NMDARs on neurons residing close to Aβ plaques and hence, to oligomeric Aβ, can account 
for reduced fosGFP expression. Besides neuronal hypoactivity, several studies additionally 
reported neuronal hyperactivity in the proximity to Aβ plaques. This was assessed utilizing a 
calcium indicator dye in the cortex (Busche, Eichhoff et al. 2008) and hippocampus (Busche, 
Chen et al. 2012) of diseased mice in vivo. They revealed neuronal hyperactivity, defined by 
increased spontaneous firing frequency, to be elicited by soluble Aβ. However, they also 
detected a fraction of hypoactive neurons in proximity to Aβ plaques (Busche, Eichhoff et al. 
2008). Furthermore experience-dependent Arc expression was found to reflect the findings 
obtained with Ca2+-imaging (Rudinskiy, Hawkes et al. 2012). Hyperactivity was not reflected 
by fosGFP expression in the present study. The different readouts can provide a possible 
explanation for this discrepancy. Another argument could be that the observed calcium 
transients were not sufficient to evoke c-fos promoter activation. Additionally, compensatory 
mechanisms might play a role in regulating the activity-dependent fosGFP expression and 
prevent a linear relationship between neuronal activity and promoter activation (Robertson, 
Kerppola et al. 1995). The density of fosGFP expressing neurons was not altered in the direct 
vicinity to Aβ plaques. This is in accordance with previously published data, which reported 
neuronal loss to be moderate (Jackson, Rudinskiy et al. 2016) or not existing (Rudinskiy, 
Hawkes et al. 2012) in the mouse model of AD utilized in this study. Taken together, reduced 
fosGFP expression in APP/PS1 mice indicates an imbalance in neuronal communication 
potentially mediated by oligomeric Aβ. 
4.3. CA1 network dynamics 
Two different populations of CA1 neurons have been identified, regarding their activity: the 
population with variable activity (ON and OFF) indicates that it acts as a reservoir of neurons 
  4 DISCUSSION 
 47 
that easily adapt to externally induced changes like novel experiences. The continuously active 
population (CON) represents the major fraction and might comprise neurons that constitute 
the backbone of the hippocampal network necessary to provide baseline computation. The fact 
that the sizes of ON, OFF and CON fractions stay constant over five days reveals the 
enormous stability of the hippocampal network. Until the development of longitudinal 
activity measurements that allow the tracking of a high number of individual neurons over 
long time-periods in vivo, the dynamics of activity could not be assessed (Lütcke, Margolis et 
al. 2013). It is a well accepted assumption that large neuronal networks achieve a continuous 
trade-off between stability and flexibility, to meet the demands of mnemonic as well as 
adjustment tasks (Lütcke, Margolis et al. 2013). The analysis of fosGFP expression changes 
neglects the fate and history of a neurons activity and just counts the daily fractions of neurons 
being recruited to (ON), released from (OFF) or kept (CON) in the active network. This 
means that neurons that keep their expression from one to the other day (CON) may lose it 
on the next (OFF) or even gain expression again (ON) and hence, might not belong to the 
permanent stable subset. However, considering the average fosGFP expression duration of 
every individual CA1 neuron revealed that the CON fraction mainly consisted of neurons 
continuously expressing fosGFP. Re-examining this population three weeks later further 
emphasizes this robust stability. Indeed, around 60% of the initial population was still active 
during another five-day imaging period (Fig. 3.3h). Whether these neurons are active 
members in an oscillating network or represent a spatial component of the mice’s daily 
environment, i.e. their home cage, needs to be further examined. The latter would ascribe 
place cell activity to this neuronal population. Long-term monitoring of place cell activity 
revealed that spatial information is represented by a unique neuronal population, with a daily 
overlap of around 15-25% (Ziv, Burns et al. 2013). However, several studies suggest that 
information coding is performed by a flexible pool of potential participants, that itself is 
constant in size but varies in the place field of individual neurons (Lütcke, Margolis et al. 
2013). That would imply that the place field does not necessarily need to be represented by a 
particular neuron. Rather the participation of the neuron in any place field represents the 
stable component. It is tempting to speculate that such a pool of neurons with flexible place 
fields is represented by the continuously fosGFP+ fraction, making up around 40% of fosGFP 
expressing neurons. The characterization of this population according to their spatial firing 
properties would need further examinations, e.g. with the expression of red-fluorescent GECIs 
in fosGFP mice. Moreover, this questions the spatial coding properties of the learning and 
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memory responsive fraction, the variable population (ON, OFF). As the potential engram 
belongs to this category, one would attribute it a mnemonic role. However, mnemonic coding 
does not necessarily exclude spatial coding. In fact, spatial firing was reported to induce LTP 
in vitro (Isaac, Buchanan et al. 2009). Likewise, to make a statement concerning spatial coding 
properties of fosGFP+ neurons, further examination of fosGFP inducing activity is required. 
This will further help to classify fosGFP+ neurons into different functional classes. In vitro 
electrophysiological data show c-fos gene expression after burst activity with 30 or more action 
potentials at frequencies of 10 Hz or more (Schoenenberger, Gerosa et al. 2009). This hints at 
Fos expression as a result of repetitive strong neuronal firing, including the possibility of a 
spatial component. In contrast, sub threshold oscillatory activity is thereby less likely to induce 
Fos expression. It is known that Aβ pathology relates to profound alterations in neuronal 
network activity (Palop, Chin et al. 2006). Here, baseline fosGFP expression changes and the 
average expression duration of fosGFP were similar in wild-type and APP/PS1 mice. This 
either suggests that the current fosGFP mouse model combined with the applied method of 
analysis is inadequate to resolve changes in network activity, or that the activation of the c-fos 
promoter itself is unable to mirror pathology-induced neuronal network alterations. 
4.4. FosGFP expression changes during learning and memory 
An increased number of ON neurons was observed after contextual fear conditioning (cFC) in 
wild-type and APP/PS1 mice. Increase of Fos expression after cFC was described before 
(Radulovic, Kammermeier et al. 1998, Tronson, Corcoran et al. 2012) and was attributed to 
the exploration of the yet novel context rather than to the aversive stimulus (Radulovic, 
Kammermeier et al. 1998, Deng, Mayford et al. 2013). Here, no difference was observed 
between wild-type and APP/PS1 mice indicating an intact response of CA1 neuronal activity 
after context exploration and hence, providing the prerequisite for contextual memory 
encoding. However, our method does not provide information about downstream signaling 
processes, leading to memory consolidation, such as strengthening of connections and 
concomitant structural changes. On the day after cFC the network returned to baseline state 
with an increased OFF fraction reducing the number of active neurons to the level observed 
during baseline. Memory retrieval led to a less pronounced increase of ON neurons, compared 
to the one induced by memory acquisition. Interestingly, the response was comparable in 
wild-type and APP/PS1 mice. Intact neuronal response during retrieval implies successful 
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encoding and consolidation. This led to the conclusion that the general network activity 
measured by fosGFP expression changes does not reflect the memory retrieval impairment of 
APP/PS1 mice on the behavioral level. Therefore, the following analysis focused on the 
activity of individual neurons and their fate during learning and memory. 
4.5. Characteristics of the reactivated neuronal ensemble 
A long-standing concept is that neuronal populations active during learning will be reactivated 
during memory retrieval. This was shown for the amygdala and different cortical and 
hippocampal regions (Reijmers, Perkins et al. 2007, Deng, Mayford et al. 2013, Tayler, 
Tanaka et al. 2013, Denny, Kheirbek et al. 2014). The size of the reactivated ensemble 
strongly depends on its information content, the brain region, the time between events and, 
not negligible, the method for labeling neurons and defining reactivation (Josselyn, Köhler et 
al. 2015). The reactivated ensemble was often calculated by the overlap of active neurons in a 
particular brain region during two events, learning and memory test. Auditory fear 
conditioning followed by retrieval three days later e.g. revealed a neuronal overlap of ∼13% in 
the basolateral amygdala (Reijmers, Perkins et al. 2007). Memory test after contextual fear 
conditioning induced a fraction of 40% reactivated neurons in hippocampal CA1 region. 
Irrespective of whether the memory test was carried out after two days (recent memory) or 14 
days (remote memory) (Tayler, Tanaka et al. 2013). However, both studies used the 
tetracycline-dependent transactivator (tTA) system that utilizes an IEG promoter for 
experience-dependent tagging of neuronal populations (TetTag system). This system requires 
the continuous supply of doxycycline (DOX) to restrict expression to a specific DOX free time 
window. Nonetheless, this time-window was two to five days long, decreasing the specificity of 
labeled neurons due to the increased amount of labeled neurons, a phenomenon referred to as 
“overtagging” (Josselyn, Köhler et al. 2015). Interestingly, the data of the present study 
revealed about 40% of CA1 neurons in the field of view to be always active, rather than just 
upon stimulus. Consequentially, the size of the reactivated neuronal population was 
overestimated by studies just considering two time-points, neglecting the neurons activity 
history. This finding was confirmed using two different definitions of reactivation to analyze 
the present data: 70% of fosGFP+ neurons during cFC also appear fosGFP+ after retrieval 
(Fig. 3.5b,c). However, this population equals the size of a randomly reactivated population 
during baseline. Restricting the definition of reactivation to neurons that switch from fosGFP- 
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to fosGFP+ during cFC and retrieval, revealed a reactivated fraction of 20% (Fig. 3.5d,e). 
Interestingly, the size of this fraction doubled compared to a randomly reactivated population 
during baseline, suggesting it to be memory-related. Hence, the potential engram was found to 
consist of around 10% of the initially activated neuronal population, subtracting the randomly 
activated fraction. This is supported by a study in rats that analyzed spatial firing of CA1 
neurons during initial and repeated exposures to an environment. The authors revealed the 
reactivated population during re-exposure to be rather small with strong spatial tuning, a 
process that was determined by the initial firing during the first exposure (Karlsson and Frank 
2008). This is especially interesting for evaluating the characteristics of memory retrieval, as it 
supports the view that retrieval is rather a reconstructive than a replicative process (Ben-Yakov, 
Dudai et al. 2015). This idea is further strengthened by computational approaches, as it is a far 
more efficient way of storing and associating information (Treves and Rolls 1994). The 
present study incorporated information about the activity history and fate of individual 
neurons and thus, provided an accurate estimation of the size of the reactivated neuronal 
population. The potential engram was found to consist of around 10% of the initially 
activated neuronal population. Corresponding with the literature, this suggests a refined 
population with high information content ensuring efficient mnemonic coding. 
4.6. Independence of cellular reactivation and memory performance 
Strikingly, the current study revealed reactivated pyramidal neurons in the CA1 region of the 
hippocampus in wild-type and APP/PS1 mice, although their memory test performance 
differed. An intact engram indeed might serve as a hint for intact consolidation, at least if 
consolidation is the underlying process for assuring reactivation of the potential engram (Ryan, 
Roy et al. 2015). Recently, it was shown that the synaptic connectivity between EC-DG 
neuronal assemblies was impaired in the same mouse model of AD. However, direct 
optogenetic stimulation of DG engram neurons during retrieval was sufficient to rescue the 
memory deficit. Simultaneous stimulation of EC and DG engram ensembles furthermore 
revealed an intact connectivity between both regions. However, the connectivity was not 
strong enough to accomplish retrieval by natural cues (Roy, Arons et al. 2016). Furthermore it 
was shown that DG engram cells inherit a certain synaptic connectivity, whose strength is 
increased upon learning. Anisomycin treatment, a common applied protein synthase inhibitor, 
prevented strengthening but not the disruption of the connectivity itself (Ryan, Roy et al. 
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2015). Taken together, the above-mentioned studies including the present suggest a deficit in 
the molecular response signals regulating synaptic strength rather than deficient structural 
connectivity per se. It was found that reactivation of CA1 neurons is necessary and sufficient 
for memory retrieval (Goshen, Brodsky et al. 2011, Ramirez, Liu et al. 2013). Of course, one 
has to keep in mind that the recruitment of CA1 neurons is just one part of a brain-wide 
engram, possibly starting in the sensory regions of the cortex further processed by the EC that 
provides input to the hippocampal trisynaptic circuit and also directly to CA1. For CA3 and 
EC, it has been shown that their inputs on CA1 dendrites are precisely timed to induce 
dendritic plateau potentials that itself provide a mechanism for feature selectivity (Bittner, 
Grienberger et al. 2015). Monitoring those events goes beyond the temporal resolution of the 
model applied in the current study, as the activation of neurons per se, does not reveal their 
temporal precision. An impairment of this complex circuitry with its necessity for synchrony 
provides a possible mechanism for memory retrieval impairment. Hence, the cellular 
reactivation observed in this study might happen independent of retrieval performance, but 
might be just not properly timed and not strong enough to provoke successful memory 
retrieval. 
4.7. Analysis of activity patterns 
FosGFP expression changes after learning and memory were shown to be comparable between 
wild-type and APP/PS1 mice. However, differences might occur on the level of individual 
neurons, hidden within the population average that itself stays constant (Lütcke, Margolis et 
al. 2013). Therefore an activity pattern analysis was performed taking into account each 
neurons’ individual activity history and fate. Assuming a single neuron has two different 
activity states (fosGFP+ and fosGFP-) and considering four imaging time-points, containing 
cFC and test, resulted in 16 possible patterns of activity (Fig. 6.2a,b). The graph depicting 
the relative frequencies of every pattern during the baseline period (BL, light grey) suggests no 
differences between wild-type and APP/PS1 mice, further confirming the finding of an intact 
home cage network (Fig. 6.2c,d). During the cFC-test period (A-A/B) the relative 
frequency of the reactivation pattern (pattern C) increased clearly in both genotypes, 
compared to BL. Remarkably, this was the only out of 15 different patterns with increased 
frequency in wild-type mice that successfully learned. This finding underscores that pattern C 
is specifically attributable to the process of memory retrieval, and further corroborates that 
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neurons exhibiting this activity pattern compose the memory trace. Moreover, APP/PS1 mice 
exposed to the conditioned context and wild-type mice exposed to a novel context shared an 
additional pattern that was found to be elevated. Their retrieval network contained newly 
recruited neurons that did not show activity before (Pattern F) (Fig. 3.5f,g and Fig. 
6.2d,e). This led to the assumption that the additional activity rather than the absence of the 
engram itself might reflect the retrieval impairment on the cellular level. 
4.8. The importance of purity for the retrieval network 
As the potential engram was intact in APP/PS1 mice, the behavioral differences may relate to 
the cellular composition of the retrieval network. Indeed, as the activity pattern data suggested 
before (Fig. 3.5f,g, Fig. 3.6.1d), the pattern F was found to be additionally upregulated 
in the retrieval network of APP/PS1 mice, comprising neurons that were present only after 
retrieval (retrieval-only neurons, RONLY). It was shown before that artificial brain-wide 
activation of a false engram during memory retrieval in the conditioned context led to 
impaired retrieval performance (Garner, Rowland et al. 2012). However, the current data 
demonstrated that superimposition of memory information by activating excitatory neurons 
exclusively in CA1 is sufficient to induce retrieval impairment (Fig. 3.6.2). Even decreasing 
the activated population to a more specific choice, i.e. context B encoding neurons, caused a 
decreased retrieval performance (Fig. 3.6.3), emphasizing the necessity of a pure engram. It 
is known that the response of CA1 is less pronounced during exposure to a familiar, compared 
to a novel environment (Karlsson and Frank 2008). This might involve a refinement of the 
responding population by “inverse synaptic tagging” on the synaptic scale (Morin, Guzman-
Ramos et al. 2015). One of the mechanisms that provide ensemble-shaping functions is the 
Arc-dependent induction of LTD. As revealed by a study (Jakkamsetti, Tsai et al. 2013), 
activity-dependent dendritic Arc expression is involved in priming neurons activated by an 
experience. Re-exposure to the same environment induced LTD via an mGluR1 (group 1 
metabotropic glutamate receptor)-dependent mechanism that required Arc (Jakkamsetti, Tsai 
et al. 2013). Further mechanisms have been described that prime neurons by changing their 
input receiving compartments influencing the dendrites’ spine composition (Okuno, Akashi et 
al. 2012) (see also 4.14.). However, a change in spine composition can lead to a 
strengthening or weakening of neuronal connections and thus, to a refinement of the 
responding neuronal population. The presence of ensemble shaping mechanisms further 
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underscores the necessity for a pure engram, shaped by experience. This led to the hypothesis 
that the CA1 immanent, non memory-specific activity in the retrieval network of APP/PS1 
mice was based on an impairment of ensemble shaping activity after learning. This further led 
to superimposition of the memory information and ultimately, to a memory retrieval deficit.  
4.9. The characteristics and regulation of potential superimposition  
The data of the present study strongly suggest that the superimposing neurons encode a 
novelty signal. Exposing mice to a novel environment, either context A or context B, induced 
increased fosGFP expression, whereas exposure to a familiar environment did not increase the 
number of fosGFP expressing neurons. This is in line with a study examining Fos expression 
after both conditioning and retrieval (Radulovic, Kammermeier et al. 1998). Another study 
demonstrated that CA1, but not CA3 produced twice as many spikes in a novel, compared to 
a familiar environment (Karlsson and Frank 2008), which is further emphasized by the finding 
that novelty-related dopamine release in the nucleus accumbens requires hippocampal activity 
(Legault and Wise 2001). Taken together, this suggests that high CA1 activity provides the 
neuronal correlate of a novelty signal. This raises the questions how CA1 judges about novelty 
or familiarity of an experience, and how this mechanism is impaired under AD-like 
conditions. Reliably answering this questions still demands further investigations. 
4.10. False mismatch detection in Alzheimer’s disease 
The assessment of information regarding its novelty involves the comparison of expectations 
dependent on past experiences, with newly incoming information, a task hypothesized to be 
carried out by the hippocampal CA1 region (Lisman and Otmakhova 2001). The present 
study discovered reactivated neurons in CA1 of mice during memory test, independent of 
their retrieval performance (Fig. 3.5e). Those possibly represent the internal hippocampal 
representation of the past experience in context A. Data of the current study indicate that 
either context re-exposure (context A) or exposure to a different but similar context (context 
B), triggers cellular recall of related representations (here: context A). This allows CA1 to 
compare both inputs: If the newly incoming information equals existing memories (match), 
CA1 will relay just the mnemonic information leading to a learned behavioral output 
(wild-type A-A). If the incoming information differs from existing memories (mismatch), CA1 
will broadcast a general novelty signal (Larkin, Lykken et al. 2014) that is hypothesized to 
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superimpose information of related memories. It is tempting to speculate that superimposition 
presents the output signal of false mismatch detection in CA1 during familiar context 
exploration in APP/PS1 mice. A mismatch-detecting property of CA1 was demonstrated 
before in mice and even in humans (Schacter, Curran et al. 1999, Kumaran and Maguire 
2006, Duncan, Ketz et al. 2012). The increase in fosGFP expression after retrieval in the 
conditioned context A in APP/PS1 mice was not as pronounced as in wild-type mice exposed 
to a novel context B (Fig. 3.4e-g). However, as their freezing rates also differ, this might 
reflect a difference in superimposition strength. APP/PS1 mice indeed learned and showed 
higher freezing rates than mice exposed to a novel context, but nevertheless display impaired 
memory retrieval. Furthermore, the retrieval network of APP/PS1 mice shared cellular features 
with mice experiencing a novel environment, represented by a population of newly fosGFP+ 
neurons (RONLY). RONLY neurons were just found elevated in the retrieval network of mice 
with no (wild-type A-B) or impaired memory (APP/PS1 A-A). It potentially comprises the 
novelty and “false” novelty encoding population in wild-type mice exposed to a novel context 
B and APP/PS1 mice exposed to the conditioned context A, respectively. It is still under 
debate, how exactly CA1 computes this comparator function. However, its multilayered 
structure with various multi-sensory inputs from several near and distant regions (Lee, 
Marchionni et al. 2014), predicts the underlying complexity of signal transformation and 
propagation within CA1 (Butler and Paulsen 2014). Its two main input regions provide 
sensory (EC layer 3, EC3) as well as mnemonic (CA3) information input, thus meeting the 
structural prerequisite for CA1 as comparator. An interesting study recorded local field 
potentials (LFPs) from several layers of CA1, CA3 and EC3, simultaneously. They found that 
gamma oscillatory input from EC3 and CA3 arrives precisely timed, and is coupled to distinct 
theta-phases at their target compartments, SLM and SR, respectively (Schomburg, Fernández-
Ruiz et al. 2014). This describes a potential way of information processing within CA1 (Butler 
and Paulsen 2014), which both is fine-tuned and prone to disturbances and, hence, provides a 
possible element of the false mismatch detection observed in APP/PS1 mice in this study. 
Summarized, the current study strongly points to superimposition being a normal 
phenomenon for dealing with novel experiences mismatching expectations. The raise of 
activity in CA1 opens a window of increased plasticity (Lisman and Otmakhova 2001) 
superimposing associations of similar memories and facilitating the encoding of new 
information. However, the superimposing activity in CA1 of APP/PS1 mice during retrieval 
denotes a failure in learning-induced ensemble shaping activity, producing a weak contextual 
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memory. The instability of the memory causes false mismatch detection, which leads to 
superimposition and further weakening of the memory. Therefore, superimposition represents 
a disease-relevant phenomenon affecting memory under AD-like conditions. 
4.11. Role of PV+ interneurons during learning and memory 
The term “memory trace” intentionally simplifies the complexity of a neuronal network 
providing a brain-wide neuronal assembly that forms a memory. The focus is mainly directed 
on the immediate learning-mediated responses of excitatory principal neurons. However, the 
modulating and shaping activity of inhibitory interneurons on principal cell output must not 
be neglected. PV-expressing (PV+) interneurons have been shown to precisely regulate CA3 
excitatory activity during learning, consolidation and memory processes (Donato, Rompani et 
al. 2013). In the present study it was demonstrated that PV+ interneuron activity in CA1 is 
necessary for successful learning and retrieval. PV+ interneuron inhibition during learning in 
wild-type mice reduced their memory retrieval performance on the next day to the level of 
APP/PS1 mice. This finding suggests an indispensable role of inhibitory drive during memory 
acquisition and hints at a possible role of PV+ interneuron malfunction in APP/PS1 mice. 
Furthermore, inhibition of PV+ interneuron impaired memory retrieval in wild-type mice. In 
our lab it was demonstrated that PV+ interneuron inhibition in CA1 led to an increased firing 
rate of CA1 pyramidal neurons (data not shown). This increased activity of CA1 pyramidal 
neurons during retrieval might superimpose the memory information. It was hypothesized that 
CA1 receives constant inhibition and that new events open a temporally restricted window of 
increased plasticity by disinhibition (Agerskov 2016). The present study supports the 
hypothesis that PV+ inhibitory interneurons regulate the CA1 plasticity window. Whether 
impaired inhibitory drive by PV+ interneurons during retrieval contributes to the retrieval 
network impurity observed in APP/PS1 mice needs to be further examined. Finally, feedback 
stimulation of PV+ interneurons with the aim to support and prolong exploration-dependent 
theta activity in APP/PS1 mice led to a rescue of their novel object recognition memory to the 
levels of wild-type mice (data not shown), confirming their necessity during learning in an 
mouse model of AD.  
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4.12. Monitoring structural plasticity of CA1 dendrites 
It was of major interest how input-receiving dendritic spines are influenced by learning and 
memory, and whether structural differences between wild-type and APP/PS1 mice provide 
evidence for underlying behavioral differences. Morphological changes in spines, which 
represent the postsynaptic part of potential synapses, have been shown to underlie and reflect 
physiological changes (Alvarez and Sabatini 2007). In the hippocampus, LTP was associated 
with the stabilization of existing and the growth of new spines, as revealed in hippocampal 
organotypic slice cultures (Engert and Bonhoeffer 1999). Long-term monitoring of baseline 
hippocampal structural plasticity via two-photon in vivo imaging has been achieved for basal 
(Attardo, Fitzgerald et al. 2015) as well as apical dendrites (Gu, Kleiber et al. 2014). However, 
learning- and memory-induced changes in the hippocampus in vivo have not been reported so 
far. In cortical regions experience-induced changes in spine number and shape were shown to 
occur not earlier than two days after learning in vivo (Lai, Franke et al. 2012). Therefore, the 
interval for monitoring spine changes in this study was chosen to cover two days. However, we 
cannot exclude that experience-induced changes on CA1 dendrites in stratum radiatum 
manifest earlier. An influence of the imaging procedure itself can be excluded, as densities and 
structural changes within groups showed no change over time during baseline imaging. All 
experience-induced structural changes have been referenced to baseline data, further avoiding a 
bias of data by the experimental approach. A possible influence of the imaging itself would 
hence be a systematic error present in all variables. Taken together, in vivo two-photon 
microscopy, combined with behavioral experiments, provide a valuable tool for monitoring 
experience-induced structural plasticity. 
4.13. Reduced spine density on CA1 pyramidal neuron dendrites 
The present study revealed a reduced spine density on apical dendrites residing in SR of CA1 
pyramidal neurons in APP/PS1 mice, which is in line with previous studies analyzing spine 
densities in the hippocampus (Bittner, Fuhrmann et al. 2010) and apical tufts of layer V 
pyramidal neurons in APP/PS1 mice (Zou, Montagna et al. 2015) and other rodent AD 
models (Shankar, Li et al. 2008, Palop and Mucke 2010). The present study extends previous 
results by showing that the reduction of total spines in APP/PS1 mice affects rather the stable 
than the transient population of dendritic spines. In the cortex, reduced spine density was 
attributed to a decrease in spine formation within 29 days (Zou, Montagna et al. 2015). This 
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raises the question whether the population of permanent spines observed in our study might 
also underlie a turnover, but with slower dynamics that cover not one, but several weeks. 
Consequentially, a reduced density in the stable spine population might also be caused by a 
reduction of spine formation. However, it is debatable whether spines in different brain 
regions have the same dynamics (Attardo, Fitzgerald et al. 2015). Thus, further investigation is 
necessary to clarify the question of long-term dynamics of hippocampal spines. Furthermore, 
the low resolution of two-photon microscopy, especially along the z-axis, might underestimate 
the density as well as turnover of spines, which might account for conflicting results (Attardo, 
Fitzgerald et al. 2015). However, in the present study wild-type and APP/PS1 mice were 
compared using the same imaging and analysis procedures. This might include a resolution-
based systematic error, but does not exclude validity of the comparison. Many studies 
investigated possible mechanisms causing reduced spine densities in mouse models of AD. The 
presence of Aβ oligomers was suggested to have a causal role in reducing spine densities. 
Oligomeric Aβ was shown to induce internalization of NMDA receptors (NMDARs), one of 
the main glutamate ionotropic receptors (Snyder, Nong et al. 2005). This can cause reduced 
glutamatergic transmission (Freir, Holscher et al. 2001), leading to synaptic failure and hence, 
decreased densities of spines on hippocampal dendrites in rodents (Shankar, Li et al. 2008, 
Palop and Mucke 2010). Additionally, Aβ oligomers were shown to alter the localization of 
NMDA receptors, thereby destabilizing spines (Um, Kaufman et al. 2013). It is assumed that 
stable spines take over mnemonic roles, in keeping life-long memories (Yang, Pan et al. 2009). 
The fact that exactly this population might be affected in the mouse model of AD emphasizes 
the severity of this structural impairment. 
4.14. Role of spine loss in learning 
The present study demonstrated an increased density of lost spines after contextual fear 
conditioning (cFC) on apical dendrites of CA1 pyramidal neurons in wild-type, but not 
APP/PS1 mice in vivo (Fig. 3.8.2b). Previous studies demonstrated selective dendritic spine 
loss after fear conditioning on layer V pyramidal neurons in the frontal association cortex of 
mice in vivo (Lai, Franke et al. 2012), suggesting similar underlying mechanisms for learning-
induced structural plasticity in the hippocampus and cortex. The loss of synapses was 
hypothesized to occur concomitant to selective strengthening of neighboring synapses, which 
is in line with electrophysiological data showing that learning-related LTP occurs just in a 
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subset of synapses (Whitlock, Heynen et al. 2006). Indeed, another study revealed spine 
reduction in the hippocampus that was found to be selective to active learning circuits. They 
hypothesized spine elimination as a mechanism to counteract the selective strengthening of 
learning-related synapses to retain a constant level of synaptic inputs (Sanders, Cowansage et 
al. 2012). Expression of the IEG Arc was described to fulfill such a refinement of synaptic 
connectivity. Accumulating after activity, it binds preferentially to inactive Ca2+-free forms of 
CamKIIβ, thereby mediating AMPA receptor endocytosis at silent synapses (Kim, Okuno et 
al. 2012). This selective elimination was named “inverse synaptic tagging” and has the 
potential to increase the contrast of synaptic weights (Kim, Okuno et al. 2012). Alterations in 
any of the participants that mediate synaptic shaping might cause alterations in mnemonic 
function. Indeed, the general expression of Arc was shown to be reduced in a triple transgenic 
mouse model of AD (Morin, Diaz-Cintra et al. 2016) and additionally revealed to be altered 
by Aβ plaque pathology in the mouse visual cortex (Rudinskiy, Hawkes et al. 2012). The 
absence of this selective structural regulation of synaptic connections in APP/PS1 mice reflects 
their learning deficit on the structural level. The present study analyzed dendrites regardless of 
their vicinity to Aβ plaques. Moreover, it was suggested that neural circuit impairments are Aβ 
plaque-independent at a late-stages of pathology (Hsia, Masliah et al. 1999). However, we 
cannot exclude that the observed alterations in structural plasticity are even more pronounced 
in the direct vicinity to Aβ plaques. Furthermore, the current study revealed learning-
dependent changes in the transient rather than in the persistent fraction of spines in wild-type 
mice. The sizes of transient spine populations were comparable in wild-type and APP/PS1 
mice during BL. However, the learning-dependent change was absent on dendrites of 
APP/PS1 mice. It is tempting to speculate that the reduction of the stable population might 
alter the general spine homeostasis, thus impairing experience-dependent shaping in APP/PS1 
mice. However, this hypothesis needs further investigation.  
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5. CONCLUSIONS AND OPEN QUESTIONS 
The current thesis identified a novel mechanism for memory impairment in a mouse model of 
AD. Moreover, a cellular engram of a contextual memory was detected in the CA1 region of 
the hippocampus. The engram was intact under AD-like conditions. However, additional 
neuronal activity during memory retrieval was found to superimpose the mnemonic 
information, impairing successful retrieval. This additional activity in CA1 resembled a 
novelty signal, suggesting false mismatch detection during familiar context exploration. 
Indeed, structural alterations of dendritic spines on CA1 pyramidal neurons and impaired 
inhibitory drive of PV+ interneurons represented potential features underlying the alterations 
on the activity level. The absence of learning-dependent spine loss on apical dendrites in 
stratum radiatum of CA1 pyramidal neurons under AD-like conditions indicates 
malfunctioning intrinsic signaling mechanisms that interfere with the strengthening of 
memory-relevant connections. This provides a prerequisite for impaired input on CA1 
pyramidal neurons and hence, strengthens the hypothesis of false mismatch detection. 
Moreover, impaired inhibition by PV+ interneurons during memory acquisition and retrieval 
might prevent the refinement of inputs on dendrites of CA1 pyramidal neurons, necessary for 
successful learning and memory retrieval. 
The molecular mechanisms underlying the observed malfunctioning dendritic spine 
remodeling and their impact on the alteration on the activity level need further examination: 
on the one hand, to clarify the relationship of both, on the other hand, to verify the exact role 
of amyloid-β in mediating the observed impairments. This is of major importance for 
developing treatment strategies that aim at the prevention of synapse malfunctions induced by 
amyloid-β. Besides, the deficits of PV+ interneurons in refine memory traces under AD-like 
conditions need further investigation to draw conclusions about their involvement in dendritic 
spine remodeling. Moreover, the validity of the hypothesized false mismatch detection in CA1 
needs to be tested. For this, electrophysiological methods as well as multi-color GECI 
approaches are well suited to analyze the strictly timed and compartmentalized inputs of CA3 
and EC on CA1 pyramidal neurons, that are suggested to malfunction under AD-like 
conditions. In addition, the characterization of fosGFP signals, e.g. by recording calcium 
transients from the same neuronal subsets, is of major interest. This will help to further testify 
spatial tuning of fosGFP+ neurons in general and with respect to the potential memory trace 
observed in this study. 
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6. APPENDIX 
6.1. Abbreviations 
AAV adeno-associated virus 
Aβ  amyloid-β 
AchE acetylcholinesterase 
AD Alzheimer's disease 
APOE apolipoprotein E 
APP amyloid precursor protein 
APP/PS1 APPswe/PS1dE9 
APPswe APP with the swedish mutation 
Arc activity-regulated cytoskeleton-associated protein 
AU arbitrary units 
BACE b-site APP cleavage enzyme 
BBB blood brain barrier 
BG background fluorescence  
BL baseline 
BP band pass filter 
BSA bovine serum albumine 
CA1 cornum ammonum 1 
CA3 cornum ammonum 3 
CamKIIβ  calcium/calmodulin-dependent protein kinase type II beta 
catFISH cellular compartment analysis of temporal activity by fluorescent in situ hybridisation 
CCK cholecystokinin 
cFC contextual fear conditioning 
CNO clozapine-N-oxide 
DG dentate gyrus 
DIO double floxed inverse open reading frame 
DMSO dimethyl sulfoxide 
Dox doxycycline 
DREADD designer receptor exclusively activated by designer drugs 
EC entorhinal cortex 
EC3 EC layer 3 
eGFP enhanced green fluorescent protein 
EOAD early-onset AD 
ERK extracellular signal-regulated kinase 
FBJ Finkel-Biskis-Jinkins 
floxed flanked by loxP sites 
Fos FBJ osteosarcoma oncogene 
fosGFP fusion construct of Fos protein and enhanced green fluorescent protein 
fosGFP-/+ fosGFP-negative/ -positive 
GAD67 67 kDa isoform of glutamic acid decarboxylase 
GECI genetically encoded calcium indicator 
GWAS  genome-wide association studies 
hM3D(Gq) mutant variant of the human M3 muscarinic (hM3) receptor, engaging Gq signaling 
H.M. Henry Molaison 
i.p. intraperitoneal 
IEG immediate early gene 
ires internal ribosomal entry site 
ITR inverted terminal repeats 
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LA lateral amygdala 
LM Learning and memory 
LOAD late-onset AD 
loxP locus of X-over P1 
LP long pass dichroic mirror 
LTD long-term depression 
LTP long-term potentiation 
MAPK mitogen-activated protein kinase 
MeXO4 methoxy-XO4 
MF mossy fibers 
mGluR1 group 1 metabotropic glutamate receptor 
MIP maximum intensity projection 
MPR massive parallel resequencing 
MTL medial temporal lobe 
NaCl sodium chloride 
NFT neurofibrillary tangles 
NMDA(R)  N-methyl-D-aspartate (receptor) 
eNpHR modified form of halorhodopsin from natronomonas 
OFT open field test 
pA polyadenylation site 
PBS phosphate buffered saline 
PET positron emission tomography 
PFA paraformaldehyde 
PP perforant path 
PSEN1dE9 mutant presinilin 1 with a deletion of exon 9 
PV parvalbumin 
PV+ parvalbumin-expressing 
REAH fosGFP+ neurons with reactivation history 
RH relative humidity 
RN retrieval network 
ROI region of interest 
RONLY neurons being fosGFP+ during retrieval only 
rpm rounds per minute 
RT room temperature 
S-LM stratum lacunosum moleculare 
s.c. subcutaneously 
SC Schaffer collaterals 
SEM standard error of the mean 
SO stratum oriens 
SOM somatostatin 
SP stratum pyramidale 
SR stratum radiatum 
TH threshold 
tTA tetracycline-controlled transactivator 
Vglut2 vesicular glutamate transporter 2 
WPRE woodchuck hepatitis virus posttranscriptional regulatory element 
YFP yellow fluorescent protein 
ZEN Zeiss efficient navigation 
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6.2. Supplementary data 
6.2.1. Intra-group changes in fosGFP expression 
 
Figure 6.1 FosGFP expression changes during learning and memory. (a) Experimental paragidm to 
monitor daily fosGFP expression of mice during learning and memory. (b-d) Fold changes of fosGFP expression 
changes in wild-type A-A (b), APP/PS1 A-A (c) and wild-type A-B mice (d). FosGFP expression changes are 
visualized green (ON, switch on), magenta (OFF, switch off) and blue (CON, continue expression). Data are 
presented as mean (continuous line) ± SEM (dashed lines). (e) Adjusted p-values for every comparison of intra-
group expression changes corresponding to graphs (b) to (d). Data from n=8 wild-type A-A mice (4775 neurons), 
n=6 APP/PS1 A-A mice (3776 neurons) and n=6 wild-type A-B mice (5099 neurons); two-way ANOVA with 
Holm-Sidak’s correction for multiple comparisons. 
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6.2.2. Relative pattern frequencies  
 
Figure 6.2 Activity pattern analysis. (a) Experimental timeline to monitor daily fosGFP expression of 
mice during learning and memory. (b) Scheme illustrating every possible activity pattern an individual neuron 
can show during four days of imaging (d2 to d5). Cyan and black circles represent fosGFP+ and fosGFP- neurons, 
respectively. Individual activity patterns were randomly assigned capital letters ranging from A to O. 
(c-e) Relative frequency of an individual pattern during baseline (BL) and learning and memory period (A-A/B) 
in wild-type A-A (c), APP/PS1 A-A (d) and wild-type A-B mice (e), respectively. Data are presented in mean 
(continuous line) ± SEM (dashed lines). Data from n=8 wild-type A-A mice (4775 neurons), n=6 APP/PS1 A-A 
mice (3776 neurons) and n=6 wild-type A-B mice (5099 neurons). 
6.2.3. Cellular and structural data 
 Statistical n 
[mice] 
Samples/n N o. of neurons or spines 
Figure 3.1d 3 wild-type  4-5 unilateral brain slices/mouse 333 Fos
+, 39 GAD67+, 4 double+  
Figure 3.1f 3 wild-type, 3 APP/PS1 
4-5 unilateral brain 
slices/mouse 
276 fosGFP+ (wild-type), 516 fosGFP+ 
(APP/PS1) 
Figure 3.2e,f,h,i 8 wild-type, 6 APP/PS1 1-3 ROIs/mouse 
2874 fosGFP+ (wild-type), 2092 
fosGFP+ (APP/PS1) 
Figure 3.3c-e 8 wild-type, 6 APP/PS1 1-3 ROIs/mouse 
4134 fosGFP+ (wild-type), 2993 
fosGFP+ (APP/PS1) 
Figure 3.3g 8 wild-type, 6 APP/PS1 1-3 ROIs/mouse 
2956 fosGFP+ at d1 (wild-type), 2198 
fosGFP+ at d1 (APP/PS1) 
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Figure 3.3h 8 wild-type, 6 APP/PS1 1-3 ROIs/mouse 
1541 fosGFP+ d1 to d5 (wild-type), 
1064 d1 to d5 (APP/PS1) 
Figure 3.4g-i,    
Figure 3.5c,e,g, 
Figure 3.6.1 
8 wild-type A-A, 
6 APP/PS1 A-A, 
6 wild-type A-B 
1-3 ROIs/mouse 
4775 fosGFP+ (wild-type A-A), 3776 
fosGFP+ (APP/PS1 A-B), 5099 
fosGFP+ (wild-type A-B) 
Figure 3.6.2e 5 CNO-treated, 4 placebo-treated 
4 unilateral brain 
slices/mouse 
1379 Fos+ (CNO-treated), 229 Fos+ 
(placebo-treated) 
Figure 3.6.3f 
8 CNO-treated, 
7 placebo-treated, 
5 non-labeled 
4 or 1 (non-labeled) 
unilateral brain 
slice(s)/mouse 
1090 Fos+ (CNO-treated), 648 Fos+ 
(placebo-treated), 98 Fos+ 
(non-labeled) 
Figure 3.8.1h-j 8 wild-type, 4 APP/PS1 2-6 dendrites/mouse 
1459 spines* (wild-type), 403 spines* 
(APP/PS1) 
Figure 3.8.2b,c,e,f 8 wild-type, 4 APP/PS1 2-6 dendrites/mouse 
516 transient spines (wild-type), 164 
transient spines (APP/PS1) 
*sum of spines on every dendrite at BL d1 (see Figure 3.8.1b). 
6.2.4. Behavioral data 
 Statistical n   
[mice] 
Analyzed time 
interval 
Figure 3.4b 
16 wild-type A-A, 
14 APP/PS1 A-A,  
10 wild-type A-B 
First 4 minutes 
Figure 3.4c 
16 wild-type A-A, 
14 APP/PS1 A-A, 
10 wild-type A-B 
First minute 
Figure 3.6.2f 5 CNO-treated, 4 placebo-treated First 4 minutes 
Figure 3.6.3g 8 CNO-treated, 7 placebo-treated First 4 minutes 
Figure 3.7e 
7 wild-type sham, 
11 wild-type NpHR, 
5 APP/PS1 sham, 
7 APP/PS1 NpHR 
First 3 minutes, 
fiber-attached 
Figure 3.7f-h 
7 wild-type sham, 
11 wild-type NpHR, 
5 APP/PS1 sham, 
7 APP/PS1 NpHR 
First 3 minutes, 
fiber-attached 
Figure 3.8.1c 10 wild-type, 8 APP/PS1 First 3 minutes 
Figure 3.8.1d 10 wild-type, 8 APP/PS1 First minute 
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6.3. List of figures 
Figure 1.1 CA1 within the hippocampal circuitry      3 
Figure 1.2 Activation of the c-fos promoter in fosGFP mice     8 
Figure 1.3 Processing of APP        10 
Figure 2.1 Hippocampal window        17 
Figure 2.2 Behavioral setups        19 
Figure 2.3 TetTag-system for activity-dependent labelling within a specified time window  21 
Figure 2.4 Definition of fosGFP expressing neurons      26 
Figure 3.1 Immunohistochemical validation of fosGFP      28 
Figure 3.2 Reduced fosGFP expression in Aβ plaque vicinity     29 
Figure 3.3 FosGFP baseline dynamics revealed two distinct neuronal populations   31 
Figure 3.4 CA1 network activity revealed to be intact in APP/PS1 mice    32 
Figure 3.5 Reactivated ensemble emerged independent of memory retrieval   34 
Figure 3.6.1 Superimposition as determinant of retrieval performance    36 
Figure 3.6.2 Artificial superimposition in CA1 impaired retrieval performance   37 
Figure 3.6.3 Superimposition by false context information in CA1 impaired retrieval performance 38 
Figure 3.7 PV+ interneurons were crucial for memory encoding and retrieval   40 
Figure 3.8.1 Altered structural plasticity in CA1 of APP/PS1 mice    42 
Figure 3.8.2 Learning-induced spine loss was absent in APP/PS1 mice    43 
Figure 6.1 FosGFP expression changes during learning and memory    62 
Figure 6.2 Activity pattern analysis        63 
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6.4. Consumables 
6.4.1. Surgery 
Designation Product no. Company 
Cyano Fast 152261 Hager Werken (Duisburg, Germany) 
Cyano Veneer® Anmischblock 152270 Hager Werken (Duisburg, Germany) 
Cyano Veneer® Einwegpinsel 152266 Hager Werken (Duisburg, Germany) 
Cyano Veneer® Pinselhalter 152267 Hager Werken (Duisburg, Germany) 
Cyano Veneer® Pulver 152255 Hager Werken (Duisburg, Germany) 
Disposable scalpels, sterile 0505 Swann-Morton (Sheffield, England) 
Drill head H71.104.004 Gebr. Basseler (Lemgo, Germany) 
EUROTUBO®, sterile collection 
swabs 
300202 DeltaLab (Barcelona, Spain) 
GRADIA® DIRECT Flo BW 2358 GC (Leuven, Belgium) 
Norland Optical Adhesive 81 NOA 81 Norland Products (Cranbury, New Jersey) 
OptiBond™ FL, two-component 
bonding agent 
26684 E Kerr (Salerno, Italy) 
Pasteur-pipette, disposable 211C COPAN (Brescia, Italy) 
Pattex, instant adhesive,  liquid n/a Henkel (Düsseldorf, Germany) 
Standard Biopsy Punch, 3 mm 48301 pfm medical (Cologne, Germany) 
Sterican® cannula, BL/LB, 27G x 
3/4" 
4657705 B Braun (Melsungen, Germany) 
Sterican® cannula, blunt, 21G x 
7/8" 
9180109 B Braun (Melsungen, Germany) 
Sterican® cannula, blunt, 27G x 1" 9180117 B Braun (Melsungen, Germany) 
Sugi®Eyespear 30601 Kettenbach (Eschenburg, Germany) 
Suture, coated VICRYL® MPV490H Ethicon (New Jersey, USA) 
TERUMO® Tuberculin Syringes SS-01T1 Terumo (Tokyo) 
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6.4.2. Behavior 
Designation Product no. Company 
Hygienic paper n/a Unigloves (Troisdorf, germany) 
6.5. Reagents 
6.5.1. Anaesthesia and medication 
Designation Product no. Company 
Bepanthen® Augen- und 
Nasensalbe (ointment) 
n/a Bayer (Leverkusen, Germany) 
Betaisodona® (Povidon-iodine) 10074524 Mundipharma (Limburg, Germany) 
Dexamethasone 21-phosphate 
disodium salt 
D1159-500MG Sigma (Darmstadt, Germany) 
Glucose 5% 11383011 B Braun (Melsungen, Germany) 
Isofluran 07253744 Actavis (New Jersey, USA) 
Ketavet® (Ketaminhydrochlorid) 
100mg.mL 
D3821-07 Pfizer (New York, USA) 
Rompun® (Xylazinhydrochloride) 
2% 
KP09X0L Bayer (Leverkusen, Germany) 
Temgesic® 
(Buprenorphinhydrochloride, 
0.324 mg) 
n/a Reckitt Benckiser Healthcare (UK)  
6.5.2. Adeno-associated viruses (AAVs) 
Designation Supplier Titer 
[vg/ml] 
AAV2/1-Fos-tTA VCF, University of Bonn n/a 
AAV2/1-PTRE-tight-hM3D(Gq)-mCherry VCF, University of Bonn n/a 
AAV1-EF1a-DIO-eNpHR-eYFP-WPRE-hGH PennVectors 1.53E+13 
AAV2-FLEX-tdTomato UNC Vector Core 4.70E+12 
AAV2-hSyn-DIO-hM3D(Gq)-mCherry UNC Vector Core 6.10E+12 
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6.5.3. Immunohistochemistry 
Designation Product no. Company 
10% normal goat serum 50062Z Life technologies (Carlsbad, USA) 
Alexa Fluor® 488 goat anti-rabbit A11008 Life technologies (Carlsbad, USA) 
Alexa Fluor® 647 goat anti-mouse A21235 Life technologies (Carlsbad, USA) 
anti-Fos, rabbit sc-52 Santa Cruz (Dallas, USA) 
anti-GAD67, mouse  MAB5406 Millipore/Merck (Darmstadt, Germany) 
anti-PV PV27 Swant (Marly, Schwitzerland) 
Bovine serum albumine 0163 Roth (Karlsruhe, Germany) 
Fluorescence mounting medium S3023 Dako/Agilent Technologies (Santa Clara, USA) 
NeuroTrace® 435/455 Nissl stain N21479 Life technologies (Carlsbad, USA) 
Phosphate buffered saline A0964 AppliChem (Darmstadt, Germany) 
Triton™-X100 A1388 Sigma-Aldrich (St. Louis, USA) 
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6.6. Equipment 
6.6.1. Microscopes  
Designation Product no. Company 
Multiphoton microscope LSM7MP n/a Carl Zeiss GmbH (Oberkochen, Germany) 
Detectors LSM BiG n/a s.a. 
Filter-set 1 (BP 450/60, 
Dichroic 490, BP 525/50) 
1756-083 s.a. 
Filter-set 2 (BP 525/50, 
Dichroic 555, BP 592.5/35) 
1756-085 s.a. 
Objective 16x (Water) CFI75 LWD 16XW Nikon Corp. (Tokio, Japan) 
Chameleon Ultra II Laser n/a Coherent, Inc. (Santa Clara, USA) 
Multiphoton microspcope Trim 
Scope II 
n/a La Vision Biotech (Bielefeld, Germany) 
Detectors H7422-40, H6780-20 Hamamatsu Photonics K.K. (Hamamatsu, Japan) 
BP460/80 BrightLine HC n/a Semrock Inc. (Rochester, USA) 
LP500 FF-1-500/LP-25 Semrock Inc. (Rochester, USA) 
LP525 ET525lp Chroma Technology Corp. (Below Falls, USA) 
LP585 T585lpxr Chroma Technology Corp. (Below Falls, USA) 
BP555/55 n/a Chroma Technology Corp. (Below Falls, USA) 
Confocal microscope LSM700 n/a Carl Zeiss GmbH (Oberkochen, Germany) 
Fixation frame for mouse in vivo 
imaging 
n/a custom build 
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6.6.2. Surgery 
Designation Product no. Company 
Auxiliary ear bars EB-5N Narishige international ltd. (London, UK) 
Control system SM7 200-100 900 7411 Luigs and Neumann (Ratingen, Germany) 
Dental drill A755983 Schick (Schemmerhofen, Germany) 
Fixation frame for mice n/a custom build 
Head holding adapter MA-6N Narishige international ltd. (London, UK) 
Heating pad 21061-90 Fine Science Tools GmbH (Heidelberg, Germany)  
LED light source KL1500 LED Schott (Mainz, Germany) 
Light-curing device, LED smart 
(420nm-480nm, 1000 W/cm2) 
14012119 Kohlschein-Dental GmbH & Co. KG (Altenberge, Germany) 
LN Junior RE/LE (3 axes) 
210-
1000000070-
RE/LE 
Luigs and Neumann (Ratingen, Germany) 
Micro4 Micro Syringe Pump 
Controller 
SYS-MICRO4 World Precision Instruments (Sarasota, USA) 
NanoFil Syringe 10 µL NANOFIL World Precision Instruments (Sarasota, USA) 
Peri-Star Pro, peristaltic pump PERIPRO-4LS World Precision Instruments (Sarasota, USA) 
Pipette holder UPN-1 Narishige (Tokyo, Japan) 
Pipette holder UPN-2 Narishige (Tokyo, Japan) 
Remote Control SM-7 200-100 900 9050 Luigs and Neumann (Ratingen, Germany) 
Stereomicroscope SZ 51 19320 Olympus (Tokyo, Japan) 
Sterilizer, Steri 250 031100 Keller (Burgdorf, Switzerland) 
UMP3 Ultra Micro Pump UMP3 World Precision Instruments (Sarasota, USA) 
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6.6.3. Behavior 
Designation Product no. Company 
Camcorder, DV -883.IR PX-8262-675 Somikon (Pearl.GmbH, Buggingen, Germany) 
Context B chamber n/a custom build 
Fear conditioning chamber n/a custom build 
Open field box n/a custom build 
Quick disconnect grid harness ENV-307W-QD Med Associates (Fairfax, Vermont) 
Shock output cable 10' SG-219G-10 DB-9 Med Associates (Fairfax, Vermont) 
Stainless steel grid floor, mouse ENV-307W-GFW Med Associates (Fairfax, Vermont) 
Stand alone shocker/scrambler 
(230V) 
ENV-414SA Med Associates (Fairfax, Vermont) 
Webcam, USB-Design 971975 - 62 Conrad Electronics SE (Hirschau, Germany) 
6.6.4. Optogenetics 
Designation Product. N o 
(customized) 
Company 
Fiberoptic Rotary Joint FRJ_1x2i_FC-2M3 Doric Lenses (Ville de Québec, 
Canada) 
Mono Fiberoptic Cannula 
MFC_300/370-
0.22_2.5mm_RMR_A45 
s.a. 
Mono Fiberoptic Patchchords 
MFP_300/330/900-
0.22_0.5m_CM3-RMC 
s.a. 
 
OBIS Laser, 100mW 34-233 Coherent, Inc. (Santa Clara, USA) 
Two-ferrules Cannula 
TFC_300/370-
0.22_2.5_TM3_FLT 
Doric Lenses (Ville de Québec, 
Canada) 
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6.6.5. Miscellaneous 
Designation Product no. Company 
Automated Vibatome VT1200 S Leica (Nussloch, Germany) 
Eppendorf Research® plus 
pipettes  
31200000XX Eppendorf (Hamburg, Germany) 
Titramax 100, shaker 544-11200-00 Heidolph (Schwabach, Germany) 
Vet Equip anesthesia system 800-466-6463 KF Technology (Rome, Italy) 
6.6.6. Software 
Designation Company 
Adobe Illustrator CS5, V ersion 
15.0.1 
Adobe Systems Inc., USA 
Adobe Photoshop CS5, V ersion 
12.1 
Adobe Systems Inc., USA 
EthoV ision XT11.5 Noldus, NL 
Fiji/ImageJ 2.0.0 Wayne Rasband, NIH, USA 
GraphPad Prism 5 & 6 GraphPad Software, Inc., USA 
ImSpector Pro LaVision BioTec GmbH, DE 
Microsoft Excel Mac 2008 Microsoft Corp., USA 
Microsoft Word Mac 2011 Microsoft Corp., USA 
Z EN  2010 Carl Zeiss AG, DE 
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6.7. Contributions and remarks 
Julia Steffen conducted the genotyping for fosGFP, YFP-H, APP/PS1, PV-Cre transgenic 
mice. She further supported with perfusions during the DREADD experiment (Fig. 3.6.2) 
and performed immunohistochemical stainings of PV-Cre mice with optical fiber 
implantations (Fig. 3.7c).  
Walker S. Jackson provided the Vglut2-ires-cre line. 
Lioba Dammer and Susanne Schoch produced and provided the AAVs composing the 
TetTag-System, namely AAV2/1-cfos-tTA and AAV2/1-PTREtight-hM3D(Gq)-mCherry via 
their viral core facility (VCF) at the university of Bonn. 
Boris Schmidt produced and provided the Aβ plaque staining compound Methoxy-XO4. 
Manuel Mittag conducted the PV+ interneuron inhibition and Eleonora Ambrad performed 
the feedback stimulation of PV+ interneurons in APP/PS1 mice mentioned on page 55 
(section 4.11). 
Parts of the current thesis compose a manuscript that was submitted for publication in 
NEURON (sections 3.1. to 3.6. and parts of 2.1. to 2.3., 2.5.2., 2.5.4., 2.6.2., 2.6.3., 2.7., 
and 2.8. are included). The manuscript with the title “Memory trace superimposition impairs 
recall in a mouse model of AD” is currently under peer-review. Concomitant, it is accessible 
via the platform Cell Press Sneak Peek that hosts manuscripts under consideration at all Cell 
Press Journals. 
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